BindingDB logo
myBDB logout

Search by Patent Identification


Patent: (prefix with "US" like US6078908)
PatentDataPatent TitleOrganizationDeposition
US9481677 37 Biaryl ether sulfonamides and their use as therapeutic agents XENON PHARMACEUTICALS INC. 10/10/17
US9493457 3 4,5,6,7-tetrahyroimidazo[4,5-c]pyridine compounds Proximagen Limited 10/09/17
US9481673 141 6-alkynyl-pyridine derivatives Boehringer ingelheim International GmbH 10/09/17
US9493431 44 Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. 10/09/17
US9493430 41 Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitors Chong Kun Dang Pharmaceutical Corp. 10/09/17
US9493474 60 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 10/09/17
US9458201 162 Melanocortin receptor-specific heptapeptides Palatin Technologies, Inc. 10/09/17
US9458171 572 Pyrrolidinyl sulfone RORγ modulators Bristol-Myers Squibb Company 10/09/17
US9505739 11 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease Merck Sharp & Dohme Corp. 10/09/17
US9464092 229 Transient protection of normal cells during chemotherapy G1 Therapeutics, Inc. 10/09/17
US9459250 254 Use of T1R3 venus flytrap region polypeptide to screen for taste modulators SENOMYX, INC. 10/09/17
US9464076 131 Benzothiophene derivative Daiichi Sankyo Company, Limited 10/02/17
US9487494 9 Cyclic hydrocarbon compounds for the treatment of diseases LEO PHARMA A/S 10/02/17
US9481685 8 Imaging neuroinflammation GE Healthcare Limited 10/02/17
US9493447 14 Optically active PDE10 inhibitor Omeros Corporation 10/02/17
US9480684 35 Orvinol and thevinol derivatives useful in the treatment of anxiety or a compulsive disorder The University of Bath 10/02/17
US9458110 632 Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors Bristol-Myers Squibb Company 10/02/17
US9458172 180 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives TBA 10/02/17
US9493429 9 Substituted benzoxazoles and methods of use thereof GENENTECH, INC.; XENON PHARMACEUTICALS INC. 10/02/17
US9458113 187 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 10/02/17
US9458176 245 Tetrahydroimidazo(1,5-D)[1,4]oxazepine derivative Eisai R&D Management Co., Ltd. 10/02/17
US9469608 44 Thrombin inhibitors Merck Sharp & Dohme Corp. 10/02/17
US9452986 683 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use AbbVie Inc. 09/25/17
US9453031 272 Chemical entities Fundación Centro Nacional de Investigaciones Oncológicas Carlos III 09/25/17
US9475814 83 Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Euroscreen S.A. 09/25/17
US9475806 21 Complement factor B inhibitors and uses there of Novartis AG 09/25/17
US9452990 131 Complement pathway modulators and uses thereof NOVARTIS AG 09/25/17
US9464060 136 Compounds Takeda Pharmaceutical Company Limited 09/25/17
US9468642 46 Imidazopyrazines BAYER INTELLECTUAL PROPERTY GMBH 09/25/17
US9447148 197 Melanocortin-1 receptor-specific cyclic peptides Palatin Technologies, Inc. 09/25/17
US9469653 23 Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 09/25/17
US9452998 274 Protein kinase C inhibitors and methods of their use NOVARTIS AG 09/25/17
US9481668 1 Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1 Merck Patent GmbH 09/25/17
US9475779 63 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 09/25/17
US9475809 16 Substituted oxopyridine derivatives and use thereof as factor xia/plasma Bayer Pharma Aktiengesellschaft 09/25/17
US9469613 4 (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide GILEAD SCIENCES, INC. 09/18/17
US9464044 101 Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient AHN-GOOK PHARMACEUTICAL CO., LTD.; BAMICHEM CO., LTD; INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION 09/18/17
US9447087 91 Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders UNIVERSITY OF UTAH RESEARCH FOUNDATION 09/18/17
US9469644 7 Inhibitors of Bruton's tyrosine kinase Hoffmann-La Roche Inc. 09/18/17
US9469639 14 Naphthylurea derivatives and medical applications thereof Radiant Pharma & Tech. Co., Ltd. 09/18/17
US9469627 3 Phenyloxadiazole derivatives as PGDS inhibitors Sanofi 09/18/17
US9434697 144 Pyrimidine FGFR4 inhibitors EISAI R&D MANAGEMENT CO., LTD. 09/18/17
US9464103 12 Spirocyclic sulfones as gamma secretase inhibitors MERCK SHARP & DOHME CORP. 09/18/17
US9434727 247 Substituted 4-phenylpiperidines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 09/18/17
US9447038 205 Substituted B-amino acid derivatives as CXCR3 receptor antagonists Sanofi 09/18/17
US9452980 625 Substituted benzamides Hoffmann-La Roche Inc. 09/18/17
US9447106 218 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators BeiGene, Ltd. 09/18/17
US9475795 111 Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases Takeda Pharmaceutical Company Limited 09/18/17
US9457039 24 2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 09/11/17
US9434725 762 5-azaindazole compounds and methods of use F. HOFFMANN-LA ROCHE AG 09/11/17
US9458145 111 Benzimidazole derivatives as bromodomain inhibitors Gilead Sciences, Inc. 09/11/17
US9453034 72 C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 09/11/17
US9458136 1 Crystalline forms and processes for the preparation of cannabinoid receptor modulators Arena Pharmaceuticals, Inc. 09/11/17
US9458135 60 Dihydroquinoline-2-one derivatives Hoffmann-La Roche Inc. 09/11/17
US9464062 6 Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 09/11/17
US9458140 29 Furanone compounds as kinase inhibitors Eternity Bioscience Inc. 09/11/17
US9453038 42 Glucokinase activator compounds, compositions containing such compounds, and methods of treatment Merck Sharp & Dohme Corp. 09/11/17
US9453048 38 IAP antagonists Bristol-Myers Squibb Company 09/11/17
US9458105 10 Inhibitors of Bruton's tyrosine kinase Hoffmann-La Roche Inc. 09/11/17
US9464073 16 Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors Acetylon Pharmaceuticals, Inc. 09/11/17
US9464081 23 Pyrrolidine derivatives and their use as complement pathway modulators Novartis AG 09/11/17
US9434711 709 Sulfonamides as TRPM8 modulators Janssen Pharmaceutica, N.V. 09/11/17
US9463192 43 Trk-inhibiting compound ONO PHARMACEUTICAL CO., LTD. 09/11/17
US9434719 783 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH NOVARTIS AG 09/05/17
US9453017 12 Antiviral therapies with phospholipase D inhibitors Vanderbilt University 09/05/17
US9447029 38 Fluorinated arylalkylaminocarboxamide derivatives NEWRON PHARMACEUTICALS S.P.A. 09/05/17
US9447090 34 Imidazopyridine compounds Astellas Pharma Inc. 09/05/17
US9447085 33 Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 09/05/17
US9446026 20 Ocular formulations for drug-delivery to the posterior segment of the eye PanOptica, Inc. 09/05/17
US9434733 75 PDE9 inhibitors with imidazo triazinone backbone H. LUNDBECK A/S 09/05/17
US9447092 48 Pharmaceutically active compounds CANCER RESEARCH TECHNOLOGY LIMITED 09/05/17
US9447091 40 Protein kinase inhibitors ORION CORPORATION 09/05/17
US9447095 30 Pyrimidine derivatives as phosphodiesterase 10 inhibitors (PDE-10) PALOBIOFARMA S.L. 09/05/17
US9453018 22 Pyrimidinones as factor XIa inhibitors Bristol-Myers Squibb Company 09/05/17
US9453021 17 Pyrimidodiazepinone compound Kyowa Hakko Kirin Co., Ltd. 09/05/17
US9434724 377 Quinuclidines for modulating alpha 7 activity ALPHARMAGEN, LLC 09/05/17
US9453023 39 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof Sanofi 09/05/17
US9452985 8 Tau imaging probe GE Healthcare Limited 09/05/17
US9428508 324 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors Centaurus BioPharma Co., Ltd. 08/28/17
US9446130 25 BTK inhibitors Merck Sharp & Dohme Corp. 08/28/17
US9433609 144 Benzimidazole-imidazole derivatives Janssen Sciences Ireland UC 08/28/17
US9428514 208 Bromodomain inhibitors AbbVie Inc. 08/28/17
US9446044 107 DYRK1 inhibitors and uses thereof DIAXONHIT 08/28/17
US9447132 2 Highly active nucleoside derivative for the treatment of HCV Achillion Pharmaceuticals, Inc. 08/28/17
US9428503 315 Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer AstraZeneca AB 08/28/17
US9428511 152 Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Bristol-Myers Squibb Company 08/28/17
US9434692 4 Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Arena Pharmaceuticals, Inc. 08/28/17
US9433622 330 Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanisms Case Western Reserve University 08/28/17
US9447057 29 Schiff bases of thiazoles: a new class of ureases inhibitors TBA 08/28/17
US9434690 357 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders Bayer Pharma Aktiengesellschaft 08/28/17
US9434693 45 Substituted pyrazoles as N-type calcium channel blockers Janssen Pharmaceutica NV 08/28/17
US9447114 29 Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives Hydra Biosciences, Inc. 08/28/17
US9428513 29 Triazolopyrazine Boehringer Ingelheim International GmbH 08/28/17
US9428505 22 Hydantoin derivative Chugai Seiyaku Kabushiki Kaisha 08/24/17
US9428469 30 Antiviral compounds HOFFMANN-LA ROCHE 08/22/17
US9447055 2 α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof Merck Serono S.A. 08/21/17
US9428456 501 1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives ACTELION PHARMACEUTICALS LTD 08/21/17
US9428504 172 7-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptor Bristol-Myers Squibb Company 08/21/17
US9428500 117 Alpha-carbolines for the treatment of cancer UNIVERSITA DEGLI STUDI DI MILANO—BICOCCA; UNIVERSITE DE GENEVE; UNIVERSITE CLAUDE BERNARD—LYON 08/21/17
US9427428 138 Benzimidazole-imidazole derivatives Janssen Sciences Ireland UC 08/21/17
US9428501 53 Bicyclic nitrogen-containing aromatic heterocyclic amide compound Astellas Pharma Inc. 08/21/17
US9446064 9 Combination therapy for treating cancer Epizyme, Inc. 08/21/17
US9428502 338 Heterocyclic modulators of lipid synthesis 3-V Biosciences, Inc. 08/21/17
US9427440 69 Macrocyclic indole derivatives useful as hepatitis C virus inhibitors Janssen Sciences Ireland UC 08/21/17
US9428460 40 N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products BAYER PHARMA AKTIENGESELLSCHAFT 08/21/17
US9428478 66 Piperazine derivatives, compositions, and uses related thereto Emory University 08/21/17
US9428476 17 S-imino-S-oxo-iminothiadiazine compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 08/21/17
US9428492 54 Secondary alcohol substituted triazoles as PDE10 inhibitors Merck Sharp & Dohme Corp. 08/21/17
US9428491 12 Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof TBA 08/21/17
US9422293 771 Tetrahydro-pyrimidoazepines as modulators of TRPV1 Janssen Pharmaceutica NV 08/21/17
US9422331 108 2-oxo-2,3,4,5-tetrahydro-1 H-benzo[B]diazepines and their use in the treatment of cancer HOFFMANN-LA ROCHE INC. 08/14/17
US9422332 92 Azaheterocycles as BIR2 and/or BIR3 inhibitors HOFFMANN-LA ROCHE INC. 08/14/17
US9428447 29 Bis-(aryl/heteroaryl)-methylene compounds, pharmaceutical compositions containing same and their use for treating cancer The Royal Institution for the Advancement of Learning/McGill University 08/14/17
US9415055 223 Cyclic amines H. Lundbeck A/S 08/14/17
US9422318 37 Epoxyeicosatrienoic acid analogs and methods of making and using the same The Medical College of Wisconsin, Inc.; The Board of Regents of the University of Texas System 08/14/17
US9427442 58 Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds Bristol-Myers Squibb Company 08/14/17
US9422240 52 Partially saturated nitrogen-containing heterocyclic compound TAISHO PHARMACEUTICAL CO., LTD 08/14/17
US9422255 40 S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 08/14/17
US9422299 205 Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists EUROSCREEN SA 08/14/17
US9416132 120 Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors Tolero Pharmaceuticals, Inc. 08/14/17
US9422235 171 Sulfonamide derivatives with therapeutic indications Pharmos Corporation 08/14/17
US9422290 38 Triazolopyridazine Boehringer Ingelheim International GmbH 08/14/17
US9422297 65 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof Duquesne University of the Holy Ghost 08/14/17
US9416129 244 Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use Merck Sharp & Dohme Corp. 08/14/17
US9422277 170 Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use Merck Sharp & Dohme Corp. 08/14/17
US9394331 44 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections Gilead Pharmasset LLC 08/07/17
US9409892 368 4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors FibroGen, Inc. 08/07/17
US9416154 45 5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 08/07/17
US9428465 17 Acid ceramidase inhibitors and their use as medicaments Fondazione Istituto Italiano Di Technologia 08/07/17
US9409895 69 Autotaxin inhibitors Novartis AG 08/07/17
US9409908 443 Dihydropyridone p1 as factor XIa inhibitors Bristol-Myers Squibb Company 08/07/17
US9409888 53 Dimeric compounds Hoffmann-La Roche Inc. 08/07/17
US9422333 28 HCV protease inhibitors and uses thereof Celgene Avilomics Research, Inc. 08/07/17
US9409917 118 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 08/07/17
US9421177 72 Imidamide sphingosine kinase inhibitors University of Virginia Patent Foundation 08/07/17
US9409907 205 Inhibitor compounds Cancer Research Technology Limited 08/07/17
US9416123 85 Kinase modulators for the treatment of cancer Synovo GmbH 08/07/17
US9428466 9 Methods for reducing uric acid levels using barbiturate derivatives TBA 08/07/17
US9416139 72 Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof SUNSHINE LAKE PHARMA CO., LTD. 08/07/17
US9409915 90 Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators Janssen Pharmaceutica NV 08/07/17
US9422307 17 2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 08/01/17
US9422324 8 6-substituted demethyl-estradiol derivatives as selective ER-β agonists Endece LLC 08/01/17
US9422312 21 Azabenzimidazole derivatives Boehringer Ingelheim International GmbH 08/01/17
US9422273 40 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response ALLERGAN, INC. 08/01/17
US9422243 55 3-phenyl-isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors NERVIANO MEDICAL SCIENCES S.R.L. a corporation 07/31/17
US9403813 270 Azetidine amide derivatives as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. 07/31/17
US9403843 72 Cysteine protease inhibitors and uses thereof THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK; THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 07/31/17
US9422263 19 Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof BAYER PHARMA AKTIENGESELLSCHAFT 07/31/17
US9422261 11 Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof PIERRE FABRE DERMO-COSMETIQUE 07/31/17
US9422231 5 Method for inhibiting Trypanosoma cruzi HOWARD UNIVERSITY 07/31/17
US9403808 195 Pyrazine derivatives Hoffmann-La Roche Inc. 07/31/17
US9409882 96 Pyridine derivatives Hoffmann-La Roche Inc. 07/31/17
US9409866 620 Pyridine-2-amides useful as CB2 agonists HOFFMANN-LA ROCHE INC. 07/31/17
US9409924 26 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 07/31/17
US9403767 182 Substituted 4-aminocyclohexane derivatives GRUENENTHAL GMBH 07/31/17
US9403801 81 Substituted heteroaryl compounds and methods of use CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD. 07/31/17
US9394309 198 Substituted phenylimidazopyrazoles and their use Bayer Pharma Aktiengesellschaft; Bayer Intellectual Property GmbH 07/31/17
US9416127 72 Triazole carboxamides and uses thereof Hoffmann-La Roche Inc. 07/31/17
US9394311 136 Triazolo compounds as PDE10 inhibitors Hoffmann-La Roche Inc. 07/31/17
US9403810 48 Carboxamide derivatives Novartis AG 07/25/17
US9409931 8 3-O-acyl-ingenol analogues LEO LABORATORIES LIMITED 07/24/17
US9408863 13 5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 07/24/17
US9409845 22 Alpha-(3,5-dimethoxybenzylidene)-alpha′-hydrocarbyl methylene cyclic ketone and preparation method thereof PHARMAXYN LABORATORIES LTD. 07/24/17
US9394297 934 Amides as pim inhibitors AMGEN INC. 07/24/17
US9403846 28 Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 07/24/17
US9403833 17 Carboxamide derivatives Novartis AG 07/24/17
US9409900 4 Compound for increasing kinase active and application thereof FUJIAN HAIXI PHARMACEUTICALS, INC.; BETTA PHARMACUETICALS CO., LTD. 07/24/17
US9416126 394 Compounds inhibiting leucine-rich repeat kinase enzyme activity Merck Sharp & Dohme Corp. 07/24/17
US9403803 15 Indole-3-carboxamides as kinase inhibitors Allergan, Inc. 07/24/17
US9403768 24 Indolines Hoffmann-La Roche Inc. 07/24/17
US9409868 44 Inhibitors of rho associated protein kinases (ROCK) and methods of use H. Lee Moffin Cancer Center and Research Institute, Inc. 07/24/17
US9409858 37 Selective histone deactylase 6 inhibitors H. Lee Moffitt Cancer Center and Research Institute, Inc.; Board of Trustees of the University of Illinois 07/24/17
US9408850 74 Substituted indazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 07/24/17
US9403827 32 Substituted purinone compounds NOVARTIS AG 07/24/17
US9403831 42 Triazolopyrazine derivative and use thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK INC. 07/24/17
US9416103 25 Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases The Board of Trustees of the University of Arkansas; The University of Kansas 07/24/17
US9394275 191 Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Theravance Respiratory Company, LLC 07/18/17
US9394273 118 Therapeutic prostaglandin receptor agonists ALLERGAN, INC. 07/18/17
US9403797 2 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Cancer Research Technology Limited 07/17/17
US9394291 20 Benzoxazinone amides as mineralocorticoid receptor modulators AstraZeneca AB 07/17/17
US9403774 6 Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors Bristol-Myers Squibb Company 07/17/17
US9394285 186 Indole and indazole compounds that activate AMPK Pfizer Inc. 07/17/17
US9394289 44 Inhibitors of c-fms kinase Janssen Pharmaceutica NV 07/17/17
US9403804 10 Inhibitors of c-fms kinase Janssen Pharmaceutica NV 07/17/17
US9388165 22 Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase HANMI PHARM. CO., LTD. 07/17/17
US9402837 20 Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase Amicus Therapeutics, Inc. 07/17/17
US9409887 14 Mutant-selective EGFR inhibitors and uses thereof Celgene Avilomics Research, Inc. 07/17/17
US9388210 17 Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same WASHINGTON UNIVERSITY 07/17/17
US9394282 406 Pyrazole carboxamides as Janus kinase inhibitors Merck Sharp & Dohme Corp. 07/17/17
US9394290 90 Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases UNIVERSITAET DES SAARLANDES CAMPUS SAARBRUECKEN 07/17/17
US9394303 31 Small molecule inhibitors of MCL-1 and uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN 07/17/17
US9393232 171 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones BeiGene, Ltd. 07/17/17
US9394263 237 Substituted hetero-azepinones F. HOFFMANN-LA ROCHE AG 07/17/17
US9394250 56 Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases ONO PHARMACEUTICAL CO., LTD. 07/17/17
US9402842 12 Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (Tdp1)—topoisomerase I (Top1) inhibitors Purdue Research Foundation 07/17/17
US9394293 17 TRPV1 antagonists including dihydroxy substituent and uses thereof Purdue Pharma L.P. 07/17/17
US9394254 6 Antibiotic and anti-parasitic agents that modulate class II fructose 1,6-bisphosphate aldolase The University of Denver and Regis University 07/10/17
US9403822 5 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. 07/10/17
US9365589 82 C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 07/10/17
US9402878 2 Depsipeptide and uses thereof NovoBiotic Pharmaceuticals, LLC 07/10/17
US9388139 97 Derivatives of celeboxib, use thereof and preparation thereof German University; Southern Research Institute 07/10/17
US9388149 69 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases GALDERMA RESEARCH & DEVELOPMENT 07/10/17
US9394307 6 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation ChemoCentryx, Inc. 07/10/17
US9388197 76 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 07/10/17
US9388198 17 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 07/10/17
US9394304 18 Imidazopyridine derivatives Hoffmann-La Roche Inc. 07/10/17
US9365582 24 Macrocyclic inhibitors of hepatitis C virus Janssen Sciences Ireland UC 07/10/17
US9388176 119 Method of treating conditiions with kinase inhibitors ALLERGAN, INC. 07/10/17
US9365572 65 PI3K and/or mTOR inhibitor Xuanzhu Pharma Co., Ltd. 07/10/17
US9403799 14 Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase MERCK PATENT GMBH 07/10/17
US9388199 44 Pyrrolidine derivatives and their use as complement pathway modulators NOVARTIS AG 07/10/17
US9388189 81 Pyrrolotriazinone derivatives as PI3K inhibitors Almirall, S.A. 07/10/17
US9388171 28 Serine/threonine kinase inhibitors GENETECH, INC.; ARRAY BIOPHARMA INC. 07/10/17
US9394276 16 Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors Bristol-Myers Squibb Company 07/10/17
US9388181 15 Substituted 1,2,3,4-tetrahydropyrido[3,4-E] pyrrolo[1,2-A]pyrimidines as kinase Allergan, Inc. 07/10/17
US9388140 120 Substituted benzimidazoles Bayer Intellectual Property GmbH 07/10/17
US9388162 146 Substituted morphinans and the use thereof Purdue Pharma L.P. 07/10/17
US9388136 35 Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof Chroma Therapeutics Ltd 07/10/17
USRE46024 22 Thyroid hormone analogs Hoffmann-La Roche Inc. 07/10/17
US9365562 126 1,3 substituted azetidine PDE10 inhibitors Merck Sharp & Dohme Corp. 07/03/17
US9364459 43 3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma Johannes Gutenberg-Universität Mainz; Universitätsmedizin der Johannes Gutenberg-Universität Mainz 07/03/17
US9365508 26 Aroyl thiourea derivatives University Court of the University of St Andrews; University Court of the University of Dundee 07/03/17
US9365534 43 Arylated camphenes, processes for their preparation and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. 07/03/17
US9365529 68 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics GALDERMA RESEARCH & DEVLOPMENT 07/03/17
US9359371 77 Bicyclic substituted pyrimidine compounds XUANZHU PHARMA CO., LTD. 07/03/17
US9365511 26 Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders ARENA PHARMACEUTICALS, INC. 07/03/17
US9359372 60 Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES 07/03/17
US9359361 20 Immune system modulators JANUS BIOTHERAPEUTICS, INC. 07/03/17
US9365575 25 Kinase inhibitors Allergan, Inc. 07/03/17
US9365853 7 Matriptase inhibitors and uses thereof against orthomyxoviridae infections TBA 07/03/17
US9365502 18 Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors WASHINGTON UNIVERSITY 07/03/17
US9365539 11 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp. 07/03/17
US9365576 279 Pyrrolopyrrolidinone compounds Novartis AG 07/03/17
US9388137 9 Quaternized amines as sodium channel blockers Purdue Pharma L.P. 07/03/17
US9394283 2 Salt form of a human histone methyltransferase EZH2 inhibitor Epizyme, Inc.; Eisai R&D Management Co., LTD. 07/03/17
US9364482 134 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 07/03/17
US9394281 12 Substituted heteroaryl compounds and methods of use CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD. 07/03/17
US9365546 8 Substituted pyridinone-pyridinyl compounds CONFLUENCE LIFE SCIENCES INC. 07/03/17
US9359399 71 Synthetic peptide amides Cara Therapeutics, Inc. 07/03/17
US9365563 228 TRPV1 antagonists including dihydroxy substituent and uses thereof Purdue Pharma L.P. 07/03/17
US9359338 366 Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents CROWN BIOSCIENCE INC. (Taiwan) 06/27/17
US9388160 4 Quinazoline derivatives as kinases inhibitors and methods of use thereof Teligene Ltd 06/27/17
US9388170 7 Substituted aminoquinazolines useful as kinases inhibitors TBA 06/27/17
US9353084 49 2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease H. Lundbeck A/S 06/26/17
US9359337 12 Acetamide derivatives Hoffmann-La Roche Inc. 06/26/17
US9359341 11 Aldehyde derivative of substitute oxazolidinones WANBURY LTD. 06/26/17
US9353089 180 Compositions and methods for the treatment of malaria Saint Louis University; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences 06/26/17
US9353101 64 Cyclic amine substituted heterocyclic CETP inhibitors Merck Sharp & Dohme Corp. 06/26/17
US9359348 11 Cyclopropyl imidazopyridine PDE10 inhibitors Merck Sharp & Dohme Corp. 06/26/17
US9365558 99 Dihydropyridinone MGAT2 inhibitors Bristol-Myers Squibb Company 06/26/17
US9359339 19 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Merck Sharp & Dohme Corp. 06/26/17
US9353093 63 Indole-1-carboxamides as kinase inhibitors Allergan, Inc. 06/26/17
US9353116 62 Methods and compositions for kinase inhibition The Regents of the University of California 06/26/17
US9353102 88 Non-annulated thiophenylamides Hoffmann-La Roche Inc. 06/26/17
US9353104 130 Substituted pyridizinone derivatives as PDE10 inhibitors Merck Sharp & Dohme Corp. 06/26/17
US9359345 12 Thiazole derivatives as inhibitors of Bruton's tyrosine kinase HOFFMANN-LA ROCHE INC. 06/26/17
US9393245 88 Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors vTv Therapeutics LLC 06/26/17
US9353061 28 3,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof ACADEMIA SINICA; NATIONAL TAIWAN UNIVERSITY 06/19/17
US9346829 31 5-HT3 receptor antagonists Takeda Phamaceutical Company Limited 06/19/17
US9353081 132 Bicyclic dihydroquinoline-2-one derivatives Hoffmann-La Roche Inc. 06/19/17
US9353075 66 Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA) The Regents of the University of California; Fondazione Istituto Italiano Di Technologia; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo” 06/19/17
US9359301 14 Ethynyl derivatives Hoffmann-La Roche Inc. 06/19/17
US9346814 250 FAP inhibitors Universiteit Antwerp; Fox Chase Cancer Center 06/19/17
US9346821 66 Heterocyclic carboxylic acid ester derivative AJINOMOTO CO., INC. 06/19/17
US9353090 331 Heterocyclic carboxylic acids as activators of soluble guanylate cyclase Boehringer Ingelheim International GmbH 06/19/17
US9351965 152 Indazole derivatives useful as ERK inhibitors Merck Sharp & Dohme Corp. 06/19/17
US9359293 24 Methods of treatment using modulators of SIRT2 CORNELL UNIVERSITY 06/19/17
US9346786 123 Pyrrolidine compounds Hoffmann-La Roche Inc. 06/19/17
US9353066 228 Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors Merck Sharp & Dohme Corp.; Merck Canada Inc. 06/19/17
US9359330 25 Substituted piperidines as sodium channel blockers Purdue Pharma L.P. 06/19/17
US9346815 934 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof Genentech, Inc. 06/12/17
US9345742 42 Aminostatin derivatives for the treatment of arthrosis MERCK PATENT GMBH 06/12/17
US9346770 29 Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. 06/12/17
US9353067 3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders ATIR Holding S.A. 06/12/17
US9353115 11 Immune system modulators JANUS BIOTHERAPEUTICS, INC. 06/12/17
US9353083 4 Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics GALDERMA RESEARCH & DEVELOPMENT 06/12/17
US9358227 12 Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. 06/12/17
US9346839 11 Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease University of Kansas 06/12/17
US9351973 15 Pyrazolopyridyl compounds as aldosterone synthase inhibitors Merck Sharp & Dohme Corp. 06/12/17
US9346794 85 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 06/12/17
US9346795 186 Substituted sulfonamides useful as antiapoptotic Bcl inhibitors Bristol-Myers Squibb Company 06/12/17
US9353113 13 Tetrahydrocarboline derivative ONO PHARMACEUTICAL CO., LTD. 06/12/17
US9346827 11 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use Amgen Inc. 06/05/17
US9346782 60 Alkyl linked quinolinyl modulators of RORγt Janssen Pharmaceutica NV 06/05/17
US9346818 42 Benzodioxole derivative and preparation method and use thereof Zhejiang Hisun Pharmaceutical Co., Ltd. 06/05/17
US9345700 53 Compositions and methods useful for treating diseases Eutropics Pharmaceuticals, Inc. 06/05/17
US9346798 678 Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors AMGEN INC. 06/05/17
US9346803 44 Indomethacin analogs for the treatment of castrate-resistant prostate cancer Vanderbilt University; The Trustees of the University of Pennsylvania 06/05/17
US9340574 25 Inhibitors of protein tyrosine phosphatases Indiana University Research and Technology Corporation 06/05/17
US9340549 193 Oxazolidinone compounds and derivatives thereof AMGEN INC. 06/05/17
US9346787 28 Piperidine compound or salt thereof TAIHO PHARMACEUTICAL CO., LTD. 06/05/17
US9339501 54 17a-hydroxylase/C17,20-lyase inhibitors NOVARTIS AG 05/31/17
US9346797 14 2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors H. Lundbeck A/S 05/31/17
US9340500 154 Aromatic heterocyclic derivative having TRPV4-inhibiting activity SHIONOGI & CO., LTD. 05/31/17
US9340537 173 Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 NOVATIS AG 05/31/17
US9334269 337 Carboxamides as inhibitors of voltage-gated sodium channels AMGEN INC. 05/31/17
US9346793 15 Hydroxylated aminotriazole derivatives as ALX receptor agonists Actelion Pharmaceuticals, LTD. 05/31/17
US9340517 531 Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor Mimetica PTY LTD 05/31/17
US9334286 108 Pharmacologically active compounds Cancer Research Technology Limited 05/31/17
US9340530 84 Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists Merck Sharp & Dohme Corp. 05/31/17
US9340507 111 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 05/31/17
US9353062 2 Substituted quinolines as bruton's tyrosine kinases inhibitors HangzhouDeRenYuCheng Biotechnology Ltd 05/31/17
US9334290 152 Substituted tetrahydrocarbazole and carbazole carboxamide compounds Bristol-Myers Squibb Company 05/31/17
US9340510 245 Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 05/31/17
US9346822 4 Thienopyrimidine compounds and use thereof Takeda Pharmaceutical Company Limited 05/31/17
US9340506 38 Acetamide derivatives as glucokinase activators, their process and medicinal applications ADVINUS THERAPEUTICS LIMITED 05/22/17
US9340573 28 Azaindolines Hoffmann-La Roche Inc. 05/22/17
US9340555 180 Compounds as tyrosine kinase modulators Allergan, Inc. 05/22/17
US9345793 20 Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi PIRAMAL IMAGING SA 05/22/17
US9334279 129 Hepatitis C virus inhibitors Bristol-Myers Squibb Company 05/22/17
US9345740 24 IAP antagonists Bristol-Myers Squibb Company 05/22/17
US9340521 130 Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives GREEN CROSS CORPORATION 05/22/17
US9340542 20 Propellane-based compounds and the use thereof Purdue Pharma L.P. 05/22/17
US9340504 6 Pyridine and piperidine derivatives as novel sodium channel blockers Purdue Pharma L.P. 05/22/17
US9346810 249 Pyrrolopyrimidine compounds and uses thereof HUTCHISON MEDIPHARMA LIMITED 05/22/17
US9334288 34 Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents The University of North Carolina at Chapel Hill 05/22/17
US9345789 13 Specific inhibitors and active site probes for legumain The Board of Trustees of the Leland Stanford Junior University 05/22/17
US9328099 1336 Cyanomethylpyrazole carboxamides as janus kinase inhibitors Merck Sharp & Dohme Corp. 05/18/17
US9333195 34 Quinuclidine derivatives and medicinal compositions containing the same ALMIRALL, S.A. 05/18/17
US9334268 25 4-amino-imidazoquinoline compounds HOFFMAN-LA ROCHE INC. 05/15/17
US9340534 4 Compounds and methods for treating ocular diseases ALLERGAN, INC. 05/15/17
US9328106 297 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use GENENTECH, INC. 05/15/17
US9339486 15 Heterocyclic modulators of cannabinoid receptors The Cleveland Clinic Foundation 05/15/17
US9333217 10 Inhibitors of human EZH2, and methods of use thereof Epizyme, Inc. 05/15/17
US9333205 6 Isoxazolo-quinazolines as modulators of protein kinase activity NERVIANO MEDICAL SCIENCES S.R.L. 05/15/17
US9333199 13 Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders BRIDGE PHARMA, INC. 05/15/17
US9340511 7 Process for making isoquinoline compounds FibroGen, Inc. 05/15/17
US9334271 32 Purine derivatives and their use in the treatment of disease Novarits AG 05/15/17
US9321790 119 Pyrimidinone derivatives as antimalarial agents Sanofi 05/15/17
US9334278 38 Pyrrolo[2,3-B]pyrazines as SYK inhibitors Hoffmann-La Roche Inc. 05/15/17
US9328096 800 Tropomyosin-related kinase inhibitors Pfizer Inc. 05/15/17
US9328120 34 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders Boehringer Ingelheim International GmbH 05/08/17
US9321791 46 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions Boehringer Ingelheim International GmbH 05/08/17
US9326978 16 A3 adenosine receptor allosteric modulators The United States of America, Represented by the Secretary, Dept. of Health and Human Services; Universiteit Leiden 05/08/17
US9321760 243 Aminopyrimidine derivatives for use as modulators of kinase activity Merck Patent GmbH 05/08/17
US9333197 9 Apoptosis signal-regulating kinase inhibitor Gilead Sciences, Inc. 05/08/17
US9321756 823 Azole compounds as PIM inhibitors AMGEN INC. 05/08/17
US9328124 3 BACE inhibitors Eli Lilly and Company 05/08/17
US9321773 21 Compounds Respivert, Ltd. 05/08/17
US9328070 8 Ethynyl derivatives Hoffmann-La Roche Inc. 05/08/17
US9328118 159 Nitrogen-containing bicyclic aromatic heterocyclic compound Astellas Pharma Inc. 05/08/17
US9328123 5 Rotenone derivatives and a use thereof Korea Atomic Energy Research Institute 05/08/17
US9328111 39 Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors BeiGene Ltd. 05/08/17
US9328112 193 Tetracyclic CDK9 kinase inhibitors AbbVie Inc. 05/03/17
US9315520 135 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides Pfizer Inc. 05/01/17
US9321748 59 Aminopyridine derived compounds as LRRK2 inhibitors H. Lundbeck A/S; Vernalis (R&D) Ltd. 05/01/17
US9321728 33 Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK PHARMACEUTICALS CO., LTD. 05/01/17
US9320741 14 Compositions and methods for treating neoplasia, inflammatory disease and other disorders DANA-FARBER CANCER INSTITUTE, INC. 05/01/17
US9321743 25 Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo” 05/01/17
US9321766 10 Kinase inhibitors Allergan, Inc. 05/01/17
US9321738 28 N-alkyltriazole compounds as LPAR antagonists HOFFMAN-LA ROCHE INC. 05/01/17
US9321752 10 Pyrazole derivative GREEN TECH CO., LTD. 05/01/17
US9321750 5 ROR modulators and their uses INNOV17 LLC 05/01/17
US9320722 81 Regulators of aldehyde dehydrogenase ALDH3A1 and related therapeutic methods Indiana University Research and Technology Corporation 05/01/17
US9320734 110 Small molecule inhibitors of the pleckstrin homology domain and methods for using same Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona 05/01/17
US20160326143 65 Compounds and uses Astrazeneca Ab 04/27/17
US9320732 21 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Incyte Corporation; Incyte Holdings Corporation 04/24/17
US9315514 32 1,3-dioxanomorphides and 1,3-dioxanocodides Rhodes Technologies 04/24/17
US9321747 21 Acid addition salt of substituted pyridine compound DAIICHI SANKYO COMPANY, LIMITED; UBE INDUSTRIES, LTD. 04/24/17
US9315498 174 Arlethynyl derivatives HOFFMAN-LA ROCHE INC. 04/24/17
US9315500 26 Bicyclic heteroaryl cycloalkyldiamine derivatives NOVARTIS AG 04/24/17
US9315489 98 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Novartis AG 04/24/17
US9315499 41 Cytomegalovirus inhibitor compounds Boehringer Ingelheim International GmbH 04/24/17
US9315519 6 Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors Bristol-Myers Squibb Company 04/24/17
US9315518 40 Imidazopyridin-2-one derivatives Merck Sharp & Dohme Corp. 04/24/17
US9321721 8 Kinase inhibitors Allergan, Inc. 04/24/17
US9315493 18 Phenylpyridine derivative and drug containing same KOWA COMPANY, LTD. 04/24/17
US9315491 129 Pyrimidine compounds as mTOR and PI3K inhibitors DEVELOPMENT CENTER FOR BIOTECHNOLOGY; DCB-USA LLC 04/24/17
US9320737 32 Substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH 04/24/17
US9315508 3 Treating diabetes with dipeptidyl peptidase-IV inhibitors Merck sharp & Dohme Corp. 04/24/17
US9303017 131 2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof Georgetown University; Duke University 04/10/17
US9303045 162 5-HT3 receptor antagonists Takeda Pharmaceutical Company Limited 04/10/17
US9303025 407 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc. 04/10/17
US9314468 140 Chemokine receptor modulators Altiris Therapeutics, Inc. 04/10/17
US9314464 22 Compounds and compositions as protein kinase inhibitors Novartis AG 04/10/17
US9315463 30 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities Almirall, S.A. 04/10/17
US9303015 151 Heteroaryl linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 04/10/17
US9315492 29 Heterocyclic group contained amino-methanol derivative, and salt, synthetic method and use thereof Beijing Foreland Biopharma Co., Ltd. 04/10/17
US9315438 10 Optically pure benzyl-4-chlorophenyl-C-glucoside derivative XUANZHU PHARMA CO., LTD 04/10/17
US9303023 145 Pyrazole and imidazole derivatives useful as orexin antagonists ACTELION PHARMACEUTICALS LTD. 04/10/17
US9303012 304 Pyridine-2-amides useful as CB2 agonists HOFFMAN-LA ROCHE INC. 04/10/17
US9303035 36 Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel Novartis AG 04/10/17
US9284322 30 Nicotinic receptor compounds Research Triangle Institute 04/04/17
US9296759 188 Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use Amgen Inc. 04/03/17
US9290488 165 Azetidine-substituted quinoxalines as opioid receptor like-1 modulators Purdue Pharma L.P. 04/03/17
US9271961 119 Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof The Trustees of the University of Pennsylvania 04/03/17
US9296741 698 Bromodomain inhibitors AbbVie Inc. 04/03/17
US9296708 17 Chimeric small molecules for the recruitment of antibodies to cancer cells YALE UNIVERSITY 04/03/17
US9302996 148 Continuous arycyclic compound MITSUBISHI TANABE PHARMA CORPORATION 04/03/17
US9278100 149 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors Pharmacyclics LLC 04/03/17
US9290476 160 Methylene linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 04/03/17
US9271963 95 Selective inhibitors of human corticosteroid synthases UNIVERSITAT DES SAARLANDES 04/03/17
US9278925 146 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one BAYER INTELLECTUAL PROPERTY GMBH 04/03/17
US9302986 97 Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH 04/03/17
US9303033 2239 Pyrazolopyrimidines and related heterocycles as CK2 inhibitors SENHWA BIOSCIENCES, INC. 03/30/17
US9302985 17 Benzyl sulfonamide derivatives as RORc modulators Genentech, Inc. 03/21/17
US9212182 776 Bicyclic sulfonamide compounds as sodium channel inhibitors Amgen Inc. 03/21/17
US9296681 36 Cycloalkylmethylamines REVIVA PHARMACEUTICALS, INC. 03/21/17
US9289400 6 D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease Drexel University; Rutgers, The State University of New Jersey 03/21/17
US9284333 390 Fused pyrroledicarboxamides and their use as pharmaceuticals Sanofi 03/21/17
US9249087 156 HDAC inhibitors and therapeutic methods using the same THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS; THE CHILDREN'S HOSPITAL OF PHILADELPHIA 03/21/17
US9290501 16 Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase Albert Einstein College of Medicine, Inc.; Victoria Link Limited 03/21/17
US9296757 92 Substituted benzothienopyrimidines BAYER PHARMA AKTIENGESELLSCHAFT 03/21/17
US9260435 16 Substituted imidazopyrazines as Akt kinase inhibitors BAYER PHARMA AKTIENGESELLSCHAFT 03/21/17
US9303018 23 Inhibitors of leukotriene production Boehringer Ingelheim International GmbH 03/13/17
US9302989 1657 NAMPT and rock inhibitors AbbVie Inc. 03/13/17
US9303019 12 Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome UNIVERSITE DE STRASBOURG 03/06/17
US9296745 236 Diacylglycerol acyltransferase 2 inhibitors Pfizer Inc. 03/06/17
US9296734 722 Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Amgen Inc. 03/06/17
US9296736 497 Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Amgen INC. 03/06/17
US9296748 113 Pyridinones Boehringer Ingelheim International GmbH 03/06/17
US9302981 6 Synthesis, methods of using, and compositions of cycloalkylmethylamines REVIVA PHARMACEUTICALS, Inc. 03/06/17
US9303005 4 Use of dibenzofuranone derivatives to inhibit kinases TBA 03/06/17
US9296747 30 Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2 Allergan, Inc. 02/28/17
US9296703 2 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors University of Utah Research Foundation 02/28/17
US9296728 26 Therapeutic compounds Regents of the University of Minnesota 02/28/17
US9284330 29 1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof Jiangsu Simovay Pharmaceutical Co., Ltd. 02/27/17
US9296693 133 Acyl piperidine inhibitors of soluble epoxide hydrolase The Regents of the University of California 02/27/17
US9284319 34 Heterocyclyl aminoimidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH 02/27/17
US9283222 773 Inhibitors of poly(ADP-ribose)polymerase AbbVie Inc. 02/27/17
US9295672 37 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof Ambit Biosciences Corporation 02/27/17
US9278978 83 6-Alkynyl Pyridine Boehringer Ingelheim International GmbH 02/21/17
US9278976 8 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp. 02/21/17
US9278981 551 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Novartis AG 02/21/17
US9284302 4 Cyclobutyl benzimidazoles as PDE 10 inhibitors Merck Sharp & Dohme Corp. 02/21/17
US9278968 106 Imidazopyridine compounds Astellas Pharma Inc. 02/21/17
US9284284 64 Oxazine derivatives and their use in the treatment of disease NOVARTIS AG 02/21/17
US9296775 3 Pyrazole compounds ELI LILLY AND COMPANY 02/21/17
US9284298 8 Pyrazolyl-pyrimidine derivatives as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 02/21/17
US9283225 2 Pyrido-pyrimidine derivatives Merck Patent GmbH 02/21/17
US9284299 58 Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactions University of Utah Research Foundation 02/21/17
US9284317 29 Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors Bayer Intellectual Property GmbH 02/21/17
US9284315 32 Three-ring PI3K and/or mTOR inhibitor ZUANZHU PHARMA CO., LTD. 02/21/17
US9290517 25 Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives Merck Sharp & Dohme Corp. 02/14/17
US9278963 124 Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors Acetylon Pharmaceuticals, Inc. 02/14/17
US9278960 315 Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Merck Sharp & Dohme Corp. 02/14/17
US9278093 8 Aldosterone synthase inhibitors Merck Sharp & Dohme Corp.; ElexoPharm GmbH 02/13/17
US9278953 14 Antagonists of prostaglandin EP3 receptor Pfizer Inc. 02/13/17
US9278930 32 Methods for increasing the stabilization of hypoxia inducible factor-α AERPIO THERAPEUTICS, INC. 02/13/17
US9278944 131 Nitrogen-containing saturated heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION; SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. 02/13/17
US8772490 5 Optically active diazabicyclooctane derivatives and process for preparing the same Meiji Seika Pharma Co., Ltd. 02/13/17
US9278954 172 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 02/13/17
US9278914 5 SARMs and method of use thereof University of Tennessee Research Foundation 02/13/17
US9278918 32 Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors Hoffmann-La Roche Inc. 02/13/17
US9290482 8 Amino-substituted imidazopyridazines BAYER PHARMA AKTIENGESELLSCHAFT 02/06/17
US9290490 33 Aminopyrimidines as Syk inhibitors Merck Sharp & Dohme Corp. 02/06/17
US9290507 137 B-RAF kinase inhibitors Boehringer Ingelheim International GmbH 02/06/17
US9290481 13 Monocyclic heteroaryl cycloalkyldiamine derivatives NOVARTIS AG 02/06/17
US9290485 183 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides NOVARTIS AG 02/06/17
US9290487 74 Pharmaceutical composition for treating diabetes AJINOMOTO CO., INC. 02/06/17
US9290459 353 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 02/06/17
US9290457 215 Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 02/06/17
US9290505 22 Substituted imidazo[1,2-a]pyrazines as Syk inhibitors Gilead Sciences, Inc. 02/06/17
US9247759 464 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof Senomyx, Inc. 02/02/17
US9290467 51 Cyclic amides HOFFMANN—LA ROCHE INC. 01/30/17
US9273046 116 Fused tricyclic compounds as Raf kinase inhibitors BeiGene, LTD. 01/30/17
US9290477 7 Inhibitors of β-secretase Vitae Pharmaceuticals, Inc. 01/30/17
US9290456 68 Pyridazinone compounds and their use as DAAO inhibitors Takeda Pharmaceutical Company Limited 01/30/17
US9290451 758 Pyridine derivatives as agonists of the CB2 receptor Hoffmann-La Roche Inc. 01/30/17
US9290463 5 Radiolabeled compounds and uses thereof The Trustees of Columbia University in the City of New York 01/30/17
US9290454 27 Substituted isoquinolines as CRTH2 receptor modulators Merck Sharp & Dohme Corp. 01/30/17
US9273053 82 Sulfur-containing heterocyclic derivative having Beta secretase inhibitory activity Shionogi & Co., Ltd. 01/30/17
US9273043 82 TRPV1 antagonists including dihydroxy substituent and uses thereof Purdue Pharma L.P.; Shionogi & Co., Ltd. 01/30/17
US9249124 141 Aurora kinase inhibitors and methods of making and using thereof H. Lee Moffitt Cancer Center and Research Institute, Inc. 01/27/17
US9273042 9 5-amino[1,4]thiazines as BACE 1 inhibitors HOFFMANN-LA ROCHE INC. 01/25/17
US9273014 82 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof Bristol-Myers Squibb Company 01/24/17
US9266877 359 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. 01/23/17
US9271969 134 Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme KAINOS MEDICINE, INC. 01/23/17
US9273021 6 Dibenzofuran derivatives as inhibitors of fructose 1,6-bisphosphatase and methods of use thereof TRUSTEES OF BOSTON COLLEGE 01/23/17
US9273052 5 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof Jiangsu Hansoh Pharmaceutical Co., Ltd. 01/23/17
US9273029 119 Pyridine-and pyrazine derivatives Merck Patent GmbH 01/23/17
US9266890 24 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Dana-Farber Cancer Institute, Inc. 01/23/17
US9271981 7 Pyrrolo[2,3-D]pyrimidine compounds Zoetis Services LLC 01/23/17
US9266883 144 Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors Novartis AG 01/23/17
US9266891 61 Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors Boehringer Ingelheim International GmbH 01/23/17
US9273011 14 Substituted pyridazines for the treatment of pain Inhibitaxin Limited 01/23/17
US9273033 142 Substituted pyridone derivatives as PDE10 inhibitors Merck Sharp & Dohme Corp. 01/23/17
US9243038 35 Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof President and Fellows of Harvard College 01/18/17
US9233167 124 Oligomer-opioid agonist conjugates Nektar Therapeutics 01/18/17
US9233947 11 Sulfamides as TRPM8 modulators Janssen Pharmaceutica, NV 01/18/17
US9266876 244 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives Actelion Pharmaceuticals Ltd. 01/17/17
US9266870 96 Heteroaromatic methyl cyclic amine derivative TAISHO PHARMACEUTICAL CO., LTD 01/17/17
US9266878 656 Phosphatidylinositol 3-kinase inhibitors Gilead Calistoga LLC 01/17/17
US9266880 8 Substituted azaindazole compounds Bristol-Myers Squibb Company 01/17/17
US9266869 118 Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitors Allergan, Inc. 01/17/17
US9266895 33 Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors Principia Biopharma Inc. 01/17/17
US9266881 22 Triazolopyridinone PDE10 inhibitors Merck Sharp & Dohme Corp. 01/17/17
US9266835 362 Quinoline derivatives useful as CB-1 inverse agonists Janssen Pharmaceutica NV 01/16/17
US9265773 422 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp.; MSD Italia S.R.L. 01/16/17
US9233921 34 Potent poxvirus inhibitor THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 01/14/17
US9266848 37 4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases GALDERMA RESEARCH & DEVELOPMENT 01/09/17
US9260455 15 Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 01/09/17
US9265734 416 Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors BIOMARIN PHARMACEUTICAL INC. 01/09/17
US9266832 90 Compounds for the treatment of neurodegenerative diseases Katholieke Universiteit Levun; K. U. Leuven R&D reMYND 01/09/17
US9260439 575 Dihydropyrrolopyrimidine derivatives PFIZER INC. 01/09/17
US9260440 123 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors BeiGene, Ltd. 01/09/17
US9266828 5 Inhibitors of Furin and other pro-protein convertases SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 01/09/17
US9266853 8 Orally available viridiofungin derivative possessing anti-HCV activity Chugai Seiyaku Kabushiki Kaisha 01/09/17
US9260450 18 Therapeutic pyrazolyl thienopyridines THESAN PHARMACEUTICALS, INC. 01/09/17
US9266839 2 Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Lycera Corporation 01/09/17
US9233965 111 3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta SANOFI 01/07/17
US9249163 241 PDE10a inhibitors for the treatment of type II diabetes JANSSEN PHARMACEUTICA NV. 12/31/16
US9492405 97 Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas The United States of America, as represented by the Secretary, Department of Health and Human Services; SRI International 12/31/16
US9260415 17 Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality Genentech, Inc. 12/28/16
US9260413 5 Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Merck Sharp & Dohme Corp. 12/28/16
US9259422 35 Orvinol and thevinol derivatives useful in the treatment of depression The University of Bath 12/28/16
US9260410 8 P38 MAP kinase inhibitors Respivert Ltd. 12/28/16
US9260425 412 Pyrazolo[3,4-c]pyridine compounds and methods of use Genetech, Inc. 12/28/16
US9259470 42 Serine/threonine kinase inhibitors Array BioPharma Inc.; Genentech, Inc. 12/28/16
US9260446 5 Synthetic methods for spiro-oxindole compounds Xenon Pharmaceuticals Inc. 12/28/16
US9260448 11 Thienopyrimidinone derivatives as mGluR1 antagonists KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 12/28/16
US9253997 33 Alkylamine derivative AJINOMOTO CO., INC. 12/20/16
US9255091 15 Benzothiazole-based pyridinium compounds The University of Montana 12/20/16
US9255107 8 Heteroaryl alkyne compound and use thereof NANJING SANHOME PHARMACEUTICAL CO., LTD. 12/20/16
US9255090 449 Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators ACTELION PHARMACEUTICALS LTD. 12/20/16
US9255110 229 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators ROCHE PALO ALTO LLC; HOFFMANN-LA ROCHE INC. 12/20/16
US9255096 26 Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors Allergan, Inc. 12/20/16
US9255106 46 Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors Shanghai Institute of Materia Medica, Chinese Academy of Sciences 12/20/16
US9255103 59 Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators Vanderbilt University 12/20/16
US9255098 6 Xanthine derivative Chengdu Easton Pharmaceutical Co., Ltd. 12/20/16
US9260417 14 Therapeutic methods and compositions involving allosteric kinase inhibition AMITECH THERAPEUTIC SOLUTIONS, INC. 12/15/16
US9249085 61 Aniline derivatives, their preparation and their therapeutic application FOVEA PHARMACEUTICALS 12/12/16
US9249151 126 Bis-amido pyridines Boehringer Ingelheim International GmbH 12/12/16
US9248140 66 Chemical compounds AstraZeneca AB 12/12/16
US9249139 9 Indolizinone based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof Council of Scientific & Industrial Research 12/12/16
US9249125 371 Pyrazole derivatives as p38 MAP inhibitors RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED 12/12/16
US9249123 8 Pyridinones/pyrazinones, method of making, and method of use thereof Genentech, Inc.; Gilead Connecticut, Inc. 12/12/16
US9249096 30 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors Bristol-Myers Squibb Company 12/12/16
US9243020 20 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 12/12/16
US9255087 12 Substituted indazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 12/12/16
US9249114 74 Thiazole derivatives Merck Patent GmbH 12/12/16
US9227979 64 Fluorescent antagonists of the A3 adenosine receptor The United States of America, as represented by The Secretary, Department of Health and Human Services; Universita Degli Studi Di Trieste; Universita Degli Studi Di Padova 12/08/16
US9260454 41 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals SANOFI 12/08/16
US9242977 42 Trk-inhibiting compound ONO PHARMACEUTICAL CO., LTD. 12/06/16
US9242988 7 2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 12/05/16
US9242996 573 Aminoheteroaryl benzamides as kinase inhibitors Novartis AG 12/05/16
US9242973 532 Chromane compounds COMENTIS, INC. 12/05/16
US9242998 118 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Merck Sharp & Dohme Corp. 12/05/16
US9243002 192 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Merck Sharp & Dohme Corp. 12/05/16
US9221809 356 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors MERCK SHARP & DOHME CORP. 11/29/16
US9242943 66 1,4 oxazines as BACE1 and/or BACE2 inhibitors SIENA BIOTECH S.P.A.; HOFFMANN-LA ROCHE INC. 11/28/16
US9242969 416 Biaryl amide compounds as kinase inhibitors Novartis AG 11/28/16
US9238625 33 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives REVIVA PHARMACEUTICALS, INC. 11/28/16
US9242981 44 Fused pyrazole derivatives as novel ERK inhibitors Merck Sharp & Dohme Corp. 11/28/16
US9242975 27 Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors Bristol-Myers Squibb Company 11/28/16
US9242995 3 Isoxazolopyridine orexin receptor antagonists MERCK SHARP & DOHME CORP. 11/28/16
US9242970 930 Lactam derivatives useful as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. 11/28/16
US9242960 4 P38MAP kinase inhibitors Respivert, Ltd. 11/28/16
US9242982 7 Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 11/28/16
US9242957 72 Thiophene-2-carboximidamide based selective neuronal nitric oxide inhibitors Northwestern University 11/28/16
US9238651 72 1-H-pyrrolo[2,3-b]pyridine derivatives MERCK PATENT GMBH 11/21/16
US9238626 42 Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's disease UNIVERSITAT DE BARCELONA; PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE 11/21/16
US9233979 458 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/21/16
US9238629 88 Heteroaryl compounds and uses thereof Celgene Avilomics Research, Inc. 11/21/16
US9241942 494 IRE-1α inhibitors MannKind Corporation 11/21/16
US9238619 76 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 11/21/16
US9233983 152 Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof ADVINUS THERAPEUTICS LIMITED 11/21/16
US9233981 33 Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 11/21/16
US9238658 49 Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors Janssen Pharmaceutica NV 11/21/16
US9238644 143 VEGFR3 inhibitors CANCER THERAPEUTICS CRC PTY LIMITED 11/21/16
US9187424 434 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Bristol-Myers Squibb Company 11/15/16
US9227969 101 Compounds and compositions as inhibitors of MEK NOVARTIS AG 11/14/16
US9233108 30 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities ALMIRALL, S.A. 11/14/16
US9233953 161 Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1 Boehringer Ingelheim International GmbH 11/14/16
US9226927 15 Gamma secretase inhibitors MERCK SHARP & DOHME CORP. 11/14/16
US9233086 100 Inhibition of WDR5 interaction with its binding partners THE REGENTS OF THE UNIVERSITY OF MICHIGAN 11/14/16
US9233968 97 Kinase inhibitors Allergan, Inc. 11/14/16
US9227975 60 Method of treatment using substituted imidazo[1,2B]pyridazine compounds Array BioPharma, Inc. 11/14/16
US9227977 14 Phosphoinositide 3-kinase inhibitors Respivert Ltd. 11/14/16
US9227973 16 Pyridine CGRP receptor antagonists Merck Sharp & Dohme Corp. 11/14/16
US9233111 72 Pyrrolo pyrimidine derivatives NOVARTIS AG 11/14/16
US9227956 98 Substituted amide compounds Pfizer Inc. 11/14/16
US9233946 59 Sulfonamide compounds KANCERA AB 11/14/16
US9227970 43 Triazolopyridine compounds Hoffmann-La Roche, Inc. 11/14/16
US9227982 56 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors NOVARTIS AG 11/08/16
US9227930 16 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 11/08/16
US9234000 417 Benzylamine derivatives as inhibitors of plasma kallikrein Kalvista Pharmaceuticals Limited 11/08/16
US9221831 451 Buprenorphine analogs Purdue Pharma, L.P. 11/08/16
US9226922 476 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/08/16
US9227959 8 Ethynyl derivatives Hoffman-La Roche Inc. 11/08/16
US9227949 188 Heteroarylcarboxylic acid ester derivative AJINOMOTO CO., INC. 11/08/16
US9221808 178 Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use H. Lee Moffitt Cancer Center and Research Institute, Inc. 11/08/16
US9226923 19 Spirocyclic molecules as protein kinase inhibitors Nanjing Allgen Pharma Co. Ltd. 11/08/16
US9216998 56 Tricyclic indole derivatives useful endothelial lipase inhibitors Janssen Pharmaceutica NV 11/08/16
US9217012 22 Inhibitors of protein tyrosine phosphatases Indiana University Research and Technology Corporation 11/02/16
US9221802 10 Arylethynyl derivatives Hoffman-La Roche Inc. 10/31/16
US9221839 30 C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 10/31/16
US9221832 152 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 10/31/16
US9221824 5 Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors Incyte Holdings Corporation; Incyte Corporation 10/31/16
US9221797 93 Inhibitors of c-fms kinase Janssen Pharmaceutica NV 10/31/16
US9221791 18 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 10/31/16
US9221828 21 N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals SANOFI 10/31/16
US9221796 174 Selective NR2B antagonists Bristol-Myers Squibb Company 10/31/16
US9216999 1840 Substituted pyrrolo[2,3-h][1,6]naphthyridines and compositions thereof as JAK inhibitors Nissan Chemical Industries, Ltd. 10/31/16
US9216984 12 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK inhibitors Incyte Corporation; Incyte Holdings Corporation 10/24/16
US9216985 41 3-aryl-2-((arylamino)methyl)quinazolin-4-(3H)-ones SciFluor Life Sciences, Inc. 10/24/16
US9221790 16 Benzamide derivatives Dong-A Pharm. Co., Ltd. 10/24/16
US9216988 210 Benzyl sulfonamide derivatives as RORc modulators Genentech, Inc. 10/24/16
US9216968 239 Heterocyclic derivative and pharmaceutical drug NIPPON SHINYAKU CO., LTD. 10/24/16
US9221795 143 Phosphatidylinositol 3-kinase inhibitors Gilead Sciences, Inc. 10/24/16
US9216981 88 Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against Raf kinase, containing same as active ingredient Medpacto, Inc. 10/24/16
US9216986 52 Quinoline derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 10/24/16
US9221767 26 Substituted phthalazinones as rock inhibitors Bristol-Myers Squibb Company 10/24/16
US9216962 216 Thiazole compounds, methods for preparation and use thereof Shanghai Puyi Chemical Co., Ltd. 10/24/16
US9216997 21 Tri-heterocyclic derivatives, preparation process and uses thereof Shanghai De Novo Pharmatech Co Ltd. 10/24/16
US9216972 69 Tricyclic heterocyclic compounds Bristol-Myers Squibb Company 10/24/16
US9090621 104 Tyrosine kinase inhibitors Principia Biopharma Inc. 10/19/16
US9212206 8 4-Fluoro-Thio-containing inhibitors of APP2, compositions thereof and method of use TBA 10/18/16
US9216182 192 Carbamate/urea derivatives containing piperidin and piperazin rings as H3 receptor inhibitors Novartis AG 10/18/16
US9206164 111 Pyrazole compounds as CRTH2 antagonists Boehringer Ingelheim International GmbH 10/18/16
US9212144 43 2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition Northwestern University 10/17/16
US9212184 4 6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors BAYER INTELLECTUAL PROPERTY GMBH 10/17/16
US9212192 59 Bicyclic carboxamide inhibitors of kinases AbbVie Inc. 10/17/16
US9212186 25 Bicyclic pyrazole LRRK2 small molecule inhibitors Genentech, Inc. 10/17/16
US9212147 64 Dihydroxy aromatic heterocyclic compound Takeda Pharmaceutical Company Limited 10/17/16
US9212171 46 Ethynyl compounds HOFFMANN-LA ROCHE INC. 10/17/16
US9212196 105 Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof UNIVERSITE PARIS DESCARTES; UNIVERSITE D'AUVERGNE 10/17/16
US9212187 13 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation OTSUKA PHARMACEUTICAL CO., LTD. 10/17/16
US9212173 37 Pyrazole aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 10/17/16
US9212178 35 Substituted pyrimidine compounds and their use as SYK inhibitors Genosco; Oscotec, Inc. 10/17/16
US9212145 3 Urea derivatives and uses thereof Kala Pharmaceuticals, Inc. 10/17/16
US9212140 12 (5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment Bayer Intellectual Property GmbH 10/11/16
US9212139 88 Aryl substituted indoles and their use as blockers of sodium channels Purdue Pharma, L.P. 10/11/16
US9212165 28 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same H. Lundbeck A/S 10/11/16
US9206201 4 Boronic acid bearing liphagane compounds as inhibitors of P13K-α and/or β Counsel of Scientific & Industrial Research 10/11/16
US9212130 181 Heterocyclic derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. 10/11/16
US9206199 217 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 10/11/16
US9206232 203 Organic compounds and their uses Novartis AG 10/11/16
US9206188 228 Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors ARRIEN PHARMACEUTICALS LLC 10/11/16
US9211296 35 Therapeutic compounds for blocking DNA synthesis of POX viruses The Trustees of the University of Pennsylvania 10/11/16
US9206173 137 Heterocyclic compounds for the treatment of stress-related conditions OTSUKA PHARMACEUTICAL CO., LTD. 10/10/16
US9216974 16 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY 10/04/16
US9206129 53 Agent for treatment of eye diseases Daito Chemix Corporation; Kyoto University 10/03/16
US9206139 65 Aggrecanase inhibitors Eli Lilly and Company 10/03/16
US9206184 219 Disubstituted benzothienyl-pyrrolotriazines and uses thereof BAYER INTELLECTUAL PROPERTY GmbH 10/03/16
US9212153 549 Inhibitors of beta-secretase Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 10/03/16
US9206198 113 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 10/03/16
US9206167 122 Piperazine-substituted benzothiophenes for treatment of mental disorders OTSUKA PHARMACEUTICAL CO., LTD. 10/03/16
US9206162 53 Triazole compounds that modulate Hsp90 activity Synta Pharmaceuticals Corp. 10/03/16
US9205085 73 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction Emory University 10/03/16
US9200020 75 6-oxopurine phosphoribosyltransferase inhibitors THE UNIVERSITY OF QUEENSLAND; INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I. 09/27/16
US9199981 176 Compounds and compositions as C-kit kinase inhibitors NOVARTIS AG 09/27/16
US9200268 5 Compounds and methods for purification of serine proteases Portola Pharmaceuticals, Inc. 09/27/16
US9199976 17 Haematopoietic-prostaglandin D2 synthase inhibitors The University of Queensland 09/27/16
US9205078 4 N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia PFIZER INC. 09/27/16
US9200006 26 Protease inhibitors MEDIVIR AB 09/27/16
US9199997 3 Purinone derivative hydrochloride ONO PHARMACEUTICAL CO., LTD. 09/27/16
US9200016 173 Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Allergan, Inc.; Exonhit Therapeutics, SA 09/27/16
US9199999 76 Substituted imidazopyrazines Bayer Intellectual Property GmbH 09/27/16
US9200001 119 Triazolyl PDE10 inhibitors Merck Sharp & Dohme Corp. 09/27/16
US9199947 140 Biaryl-propionic acid derivatives and their use as pharmaceuticals Sanofi 09/20/16
US9199927 112 Guanidinobenzoic acid compound Astellas Pharma Inc. 09/20/16
US9199944 157 N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 09/20/16
US9199949 11 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 09/20/16
US9193689 18 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) 09/19/16
US9187487 46 Azaindole derivatives as tyrosine kinase inhibitors PRINCIPIA BIOPHARMA, INC. 09/19/16
US9192603 67 Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 09/19/16
US9193697 39 Oxazole derivatives useful as modulators of FAAH MERCK SHARP & DOHME CORP. 09/19/16
US9193736 311 PDE 10a inhibitors for the treatment of type II diabetes Janssen Pharmaceutica, NV 09/19/16
US9193762 57 Selective inhibitors of prolylcarboxypeptidase UNIVERSITY OF MISSISSIPPI 09/19/16
US9193726 73 Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Pfizer Inc. 09/19/16
US9187470 12 Anti-mucus drugs and uses therefor Washington University 09/12/16
US9187477 16 Azabenzimidazole derivatives Boehringer Ingelheim International GmbH 09/12/16
US9187486 205 Bicyclic pyridazine compounds as Pim inhibitors AMGEN INC. 09/12/16
US9187466 60 Bisaryl-bonded aryltriazolones and use thereof Bayer Intellectual Property GmbH 09/12/16
US9187469 20 Morpholinylbenzotriazines for use in cancer therapy Merck Patent GmbH 09/12/16
US9187480 48 Peripherally restricted diphenyl purine derivatives Research Triangle Institute 09/12/16
US9187459 10 Quinazoline-7-ether compounds and methods of use NewGen Therapeutics, Inc. 09/12/16
US9187474 8 Raf inhibitor compounds Deciphera Pharmaceuticals, LLC; Eli Lilly and Company 09/12/16
US9187437 45 Substituted oxadiazole compounds BRISTOL-MYERS SQUIBB COMPANY 09/12/16
US9187450 56 Substituted pyridine compound Daiichi Sankyo Company, Limited 09/12/16
US9187462 122 Substituted quinazolines as serine/threonine kinase inhibitors Array BioPharma Inc.; Genentech, Inc. 09/12/16
US9187441 88 p53-Mdm2 antagonists University of Pittsburgh—Of the Commonwealth System of Higher Education 09/12/16
US9187406 25 Curcumin analogues as zinc chelators and their uses The Research Foundation of State University of New York; Chem-Master International, Inc. 09/06/16
US9182402 47 Hepsin inhibitors Fred Hutchinson Cancer Research Center 09/06/16
US9181263 149 Inhibitors of bruton's tyrosine kinase PHARMACYCLICS LLC 09/06/16
US9187413 6 Peripherally restricted FAAH inhibitors The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino 09/06/16
US9187429 211 Phenyl-tetrahydroisoquinoline derivatives HOFFMANN-LA ROCHE INC. 09/06/16
US9187430 9 Poly (ADP-ribose) polymerase inhibitor CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD. 09/06/16
US9186318 31 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof Beijing Konruns Pharmaceutical Co., Ltd 09/06/16
US9187428 150 Substituted dicyanopyridines and use thereof Bayer Intellectual Property GmbH 09/06/16
US9187397 23 Therapeutic curcumin derivatives STC.UNM 09/06/16
US9186360 490 Treatment of respiratory disorders using TRPA1 antagonists GLENMARK PHARMACEUTICALS S.A. 09/06/16
US9181266 321 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors NOVARTIS AG 08/29/16
US9181236 290 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use Merck Sharp & Dohme Corp. 08/29/16
US9181253 52 Adenosine receptor agonists, partial agonists, and antagonists The United States of America, as represented by the Secretary, Department of Health and Human Services 08/29/16
US9181272 300 Aldosterone synthase inhibitors Boehringer Ingelheim International GmbH 08/29/16
US9181279 16 Cyclic amine derivatives as EP4 receptor antagonists ROTTAPHARM BIOTECH S.R.L. 08/29/16
US9181233 28 Inhibitors of glutaminyl cyclase PROBIODRUG AG 08/29/16
US9181275 4 Mercaptoamidine derivatives and methods of use AbbVie Inc. 08/29/16
US9181258 130 Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 08/29/16
US9181249 142 Substituted pyrido[3,4-b]pyrazines as GPR6 modulators Takeda Pharmaceutical Company Limited 08/29/16
US9181261 10 TrkA kinase inhibitors, compositions and methods thereof Merck Sharp & Dohme Corp. 08/29/16
US9181181 77 2-substituted-3-phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease Albireo AB 08/15/16
US9180122 35 5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain Takeda Pharmaceutical Company Limited 08/15/16
US9181219 48 Compounds of modulating TRPV3 function HYDRA BIOSCIENCES, INC. 08/15/16
US9180116 72 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Cayman Chemical Company, Inc. 08/15/16
US9175357 23 Fragment ligated inhibitors selective for the polo box domain of PLK1 UNIVERSITY OF SOUTH CAROLINA 08/15/16
US9181185 25 Heteroaryl compounds as sodium channel blockers Purdue Pharma L.P. 08/15/16
US9181184 18 Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives Amicus Therapeutics, Inc. 08/15/16
US9181230 110 Morpholine compounds and uses thereof Hoffmann-La Roche Inc. 08/15/16
US9180183 18 Phospholipid drug analogs Telormedix SA 08/15/16
US9181182 40 S1P receptors modulators Akaal Pharma PTY LTD 08/15/16
US9180120 38 Substituted N-phenethyltriazoloneacetamides and use thereof Bayer Intellectual Property GmbH 08/15/16
US9181187 12 Therapeutic agent for urinary excretion disorder ONO PHARMACEUTICAL CO., LTD. 08/15/16
US9180192 46 mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 08/15/16
US9174997 29 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof Bayer Intellectual Property GmbH 08/08/16
US9174982 360 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC.; GENENTECH, INC.; THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH 08/08/16
US9175000 27 Buprenorphine analogs Purdue Pharma L.P. 08/08/16
US9174969 73 Indoline scaffold SHP-2 inhibitors and cancer treatment method UNIVERSITY OF SOUTH FLORIDA 08/08/16
US9175331 256 Inhibitors of human EZH2, and methods of use thereof Epizyme, Inc. 08/08/16
US9174974 85 Macrocyclic factor VIIa inhibitors Bristol-Myers Squibb Company 08/08/16
US9174999 20 Methods and compositions for studying, imaging, and treating pain The Board of Trustees of the Leland Stanford Junior University 08/08/16
US9174993 27 N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals SANOFI 08/08/16
US9175320 1 Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof Arena Pharmaceuticals, Inc. 08/08/16
US9175003 234 Substituted azoanthracene derivatives and intermediates for preparation thereof vTv Therapeutics LLC 08/08/16
US9173884 107 Inhibitors of phosphodiesterase 11 (PDE11) Trustees of Boston College 08/02/16
US9173935 18 Phospholipid drug analogs Telormedix SA 08/02/16
US9174965 6 Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators Bristol-Myers Squibb Company 08/02/16
US9174940 29 TSH receptor antagonizing tetrahydroquinoline compounds Merck Sharp & Dohme B.V. 08/02/16
US9169270 120 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators Actelion Pharmaceuticals Ltd. 08/01/16
US9169260 399 Amidopyrazole inhibitors of interleukin receptor-associated kinases MERCK SHARP & DOHME CORP. 08/01/16
US9173879 6 Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof Bristol-Myers Squibb Company 08/01/16
US9173869 43 Mediators of hedgehog signaling pathways, compositions and uses related thereto CURIS, INC. 08/01/16
US9169246 207 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof SANOFI 08/01/16
US9073941 179 Compounds and methods for treating tuberculosis infection Academia Sinica 07/26/16
US9169224 209 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase Janssen Pharmaceutica NV 07/26/16
US9169243 45 Apoptosis signal-regulating kinase inhibitors Gilead Sciences, Inc. 07/25/16
US9169209 118 Compounds and compositions for the inhibition of NAMPT FORMA TM, LLC 07/25/16
US9169252 645 Heteroaryl substituted nicotinamide compounds Bristol-Myers Squibb Company 07/25/16
US9169259 92 Imidazopyridazine compounds HOFFMANN-LA ROCHE INC. 07/25/16
US9169240 92 Ketone linked benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 07/25/16
US9079895 129 Morpholino compounds, uses and methods University of Dundee 07/25/16
US9169234 24 Sepiapterin reductase inhibitors for the treatment of pain Children's Medical Center Corporation 07/25/16
US9163017 17 Anti-viral compounds ABBVIE INC. 07/18/16
US9168247 6 Beta carboline derivatives useful in the treatment of proliferative disorders FACULTES UNIVERSITAIRES NOTRE DAME DE LA PAIX; UNIVERSITE LIBRE BRUXELLES 07/18/16
US9163012 94 Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 Vitae Pharmaceuticals, Inc. 07/18/16
US9163011 106 Oxazine derivatives and their use in the treatment of disease NOVARTIS AG 07/18/16
US9163042 24 Prodrugs of pyridone amides useful as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 07/18/16
US9163015 90 Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 07/18/16
US9169205 200 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 07/18/16
US9163021 236 Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors Pfizer Limited 07/18/16
US9168248 27 Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase Merck Canada Inc. 07/18/16
US9163040 1 Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors NOVARTIS AG 07/18/16
US9163013 34 Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. 07/18/16
US9162979 50 1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors ROTTAPHARM BIOTECH S.R.L. 07/11/16
US9161945 2 4-isopropyl-6-methoxyphenyl glucitol compound TAISHO PHARMACEUTICAL CO., LTD. 07/11/16
US9163003 106 4-piperidinyl compounds for use as tankyrase inhibitors NOVARTIS AG 07/11/16
US9163007 94 5-substituted indazoles as kinase inhibitors AbbVie Inc. 07/11/16
US9169182 4 Chrysophaentin analogs that inhibit FtsZ protein THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 07/11/16
US9162991 55 Cinnamoyl inhibitors of transglutaminase University of Ottawa 07/11/16
US9156822 144 Functionally selective ligands of dopamine D2 receptors The University of North Carolina at Chapel Hill 07/11/16
US9163010 3 Indolinone protein kinase inhibitors Beta Pharma, Inc. 07/11/16
US9163008 122 Pyrimidines as sodium channel blockers Purdue Pharma, L.P. 07/11/16
US9161939 7 Pyrrolo[2,3-d]pyrimidine compounds Zoetis Services LLC 07/11/16
US9168255 39 Quinazoline compounds as sodium channel blockers Purdue Pharma L.P. 07/11/16
US9162983 5 Reactivators of organophosphorous inhibited acetylcholinesterase SOUTHWEST RESEARCH INSTITUTE 07/11/16
US9156845 422 4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors Pfizer Inc. 06/30/16
US9161922 34 Amine oxidase inhibitors Case Western Reserve University 06/30/16
US9156856 44 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc. 06/30/16
US9156831 41 Chemical compounds AstraZeneca AB 06/30/16
US9156829 308 Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED 06/30/16
US9161924 6 Factor IXa inhibitors Merck Sharp & Dohme Corp. 06/30/16
US9156830 87 Heterocyclic compounds SHIONOGI & CO., LTD. 06/30/16
US9156852 39 Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases HANMI PHARM. CO., LTD 06/30/16
US9156848 4 Treating diabetes with dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 06/30/16
US9156836 5 Tricyclic triazole compounds that modulate HSP90 activity Synta Pharmaceuticals Corp. 06/30/16
US9150566 561 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. 06/20/16
US9150578 174 5,8-dihydro-6H-pyrazolo[3,4-h]quinazolines as IGF-1R/IR inhibitors Boehringer Ingelheim International GmbH 06/20/16
US9150526 208 Biaryl-propionic acid derivatives and their use as pharmaceuticals Sanofi 06/20/16
US9155743 90 Bicyclic heterocycle compounds and their uses in therapy ASTEX THERAPEUTICS LIMITED 06/20/16
US9150583 8 Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation Boehringer Ingelheim International GmbH 06/20/16
US9150577 239 Heterocyclic compounds containing an indole core Boehringer Ingelheim International GmbH 06/20/16
US9156811 829 N-myristoyl transferase inhibitors Univeristy of Dundee 06/20/16
US9150581 30 Nicotinic receptor compounds RESEARCH TRIANGLE INSTITUTE; THE REGENTS OF THE UNIVERSITY OF MICHIGAN; VIRGINIA COMMONWEALTH UNIVERSITY 06/20/16
US9150579 6 Selective PI3K delta inhibitors RHIZEN PHARMACEUTICALS SA 06/20/16
US9156810 66 Treatment of inflammatory bowel disease Allergan, Inc. 06/20/16
US9150519 242 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis MERCK SERONO SA 06/14/16
US9145414 77 1,2,4-triazine-6-carboxamide derivative TAIHO PHARMACEUTICAL CO., LTD. 06/13/16
US9149477 5 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta ICOS Corporation 06/13/16
US9145402 38 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 06/13/16
US9145391 266 Bipyridylaminopyridines as Syk inhibitors Merck Sharp & Dohme Corp.; Merck Canada Inc. 06/13/16
US9145380 240 Bis-(sulfonylamino) derivatives for use in therapy Astrazeneca AB 06/13/16
US9144538 75 Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin The Procter & Gamble Company 06/13/16
US9145392 772 Imidazole amines as modulators of kinase activity Merck Patent GmbH 06/13/16
US9145419 10 Imidazopyridazinyl compounds Bristol-Myers Squibb Company 06/13/16
US9150527 8 Metalloenzyme inhibitor compounds Innocrin Pharmaceuticals, Inc. 06/13/16
US9149492 26 Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease Trustees of Dartmouth College 06/13/16
US9145354 231 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED 06/13/16
US9145426 38 Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 06/13/16
US9145412 77 Selective HDAC1 and HDAC2 inhibitors ACETYLON PHARMACEUTICALS, INC. 06/13/16
US9145418 10 Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 06/13/16
US9145408 44 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators Purdue Pharma L.P.; Shionogi & Co., Ltd. 06/13/16
US9150544 176 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application Sanofi 06/13/16
US9150546 325 Triazine derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. 06/13/16
US9139578 26 Amide or urea containing benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 06/06/16
US9139593 21 Azetidine compounds, compositions and methods of use HOFFMANN-LA ROCHE INC. 06/06/16
US9138393 75 Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin The Procter & Gamble Company 06/06/16
US9139568 167 Heterocyclic carboxamides as modulators of kinase activity Merck Patent GmbH 06/06/16
US9139585 51 Inhibitors of the Renal Outer Medullary Potassium channel Merck Sharp & Dohme Corp. 06/06/16
US9138431 13 Methods of treatment of histamine H-4 receptor-related pruritus BRIDGE PHARMA, INC. 06/06/16
US9138494 8 Radiolabeled PDE10A ligands AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 06/06/16
US9139529 80 Substituted quinoxalines as sodium channel modulators VERTEX PHARMACEUTICALS INCORPORATED 06/06/16
US9139577 328 Sulfoximine substituted quinazolines for pharmaceutical compositions Boehringer Ingelheim International GmbH 06/06/16
US9139546 32 Tri-aryl/heteroaromatic cannabinoids and use thereof The University of Tennessee Research Foundation 06/06/16
US9138423 2 Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria Asociación Centro de Investigación Cooperativa en Biociencias—CIC Biogune 06/06/16
US9133180 33 Aurora and FLT3 kinases modulators SAREUM LIMITED 05/23/16
US8772323 260 Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists Boehringer Ingelheim International GmbH 05/23/16
US9133171 193 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group Bayer Intellectual Property GmbH 05/23/16
US8829029 164 Dual modulators of 5HT2A and D3 receptors Hoffmann-La Roche Inc. 05/23/16
US9133183 27 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities Deciphera Pharmaceuticals, LLC 05/23/16
US9133201 12 Inhibitors of Bruton's tyrosine kinase PHARMACYCLICS, INC. 05/23/16
US9133197 12 Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. 05/23/16
US8865745 19 Pyrazolone derivatives as PDE4 inhibitors Takeda GmbH 05/23/16
US9133199 2 Pyrimidine derivatives as protein kinase inhibitors Cyclacel Limited 05/23/16
US9133182 37 Selective androgen receptor modulators Radius Health, Inc. 05/23/16
US9133187 85 Serine/threonine kinase inhibitors ARRAY BIOPHARMA INC.; GENENTECH, INC. 05/23/16
US9132129 8 Antiviral compounds KATHOLIEKE UNIVERSITEIT LEUVEN 05/16/16
US9133148 91 Carbamate compounds and of making and using same The Scripps Research Institute; Abide Therapeutics, Inc. 05/16/16
US9133157 134 HIV protease inhibitors Merck Canada Inc. 05/16/16
US9133134 1 Inhibitors of bruton's tyrosine kinase PHARMACYCLICS LLC 05/16/16
US9132134 10 Methods for treating GI tract disorders Neurogastrx, Inc. 05/16/16
US9133125 72 Morphan and morphinan analogues, and methods of use ALKERMES PHARMA IRELAND LIMITED 05/16/16
US9133168 168 Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors SANOFI 05/16/16
US9133131 27 Pyrimidine diol amides as sodium channel blockers Purdue Pharma L.P. 05/16/16
US9133160 15 Substituted benzimidazole and imidazopyridine compounds useful as CYP17 modulators Bristol-Meyers Squibb Company 05/16/16
US9133162 13 Substituted quinoline compounds and methods of use SUNSHINE LAKE PHARMA CO., LTD.; CALITOR SCIENCES, LLC 05/16/16
US9133105 4 Transcription factor modulators C&C BIOPHARMA, LLC 05/16/16
US9126978 10 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties The Regents of the University of Michigan 05/09/16
US9126979 24 Compounds for inhibiting the interaction of BCL2 with binding partners Novartis AG 05/09/16
US9126980 90 Compounds for inhibiting the interaction of BCL2 with binding partners Novartis AG 05/09/16
US9127027 37 Epoxyeicosatrienoic acid analogs and methods of making and using the same The Medical College of Wisconsin, Inc.; The Board of Regents of the University of Texas System 05/09/16
US9126987 25 Inhibitors of glutaminyl cyclase PROBIODRUG AG 05/09/16
US9127005 20 Isoform selective phospholipase D inhibitors Vanderbilt University 05/09/16
US9126952 67 Morpholinylquinazolines Merck Patent GmbH 05/09/16
US9126973 76 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases CAYMAN CHEMICAL COMPANY, INCORPORATED 05/09/16
US9126957 10 Selective glycosidase inhibitors and uses thereof MERCK SHARP & DOHME CORP.; ALECTOS THERAPEUTICS, INC. 05/09/16
US9127001 68 Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them Sanofi 05/09/16
US9126976 41 Substituted benzopiperazines as CETP inhibitors Merck Sharp & Dohme Corp. 05/09/16
US9125915 17 Antitumor agent Mitsubishi Tanabe Pharma Corporation 05/02/16
US9125913 853 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases AbbVie Inc. 05/02/16
US9126948 14 Pyrimidine-4,6-diamine derivatives as PI3K inhibitors Incyte Holdings Corporation; Incyte Corporation 05/02/16
US9120812 515 Pyrimidooxazocine derivatives as mTOR-inhibitors Sanofi 05/02/16
US9120838 4 Saccharide conjugates Curators of the University of Missouri 05/02/16
US9120808 141 Substituted clavulanic acid NABRIVA THERAPEUTICS AG 05/02/16
US9126947 6 Substituted pyridazine carboxamide compounds Xcovery Holding Company LLC 05/02/16
US9126931 266 Tetracyclic compound Chugai Seiyaku Kabushiki Kaisha 05/02/16
US9126941 39 Treatment of hyperproliferative disorders with diarylhydantoin compounds The Regents of the University of California 05/02/16
US9120798 50 Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of P2Y1 receptor Bristol-Myers Squibb Company 04/25/16
US9120769 172 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline Boehringer-Ingelheim International GmbH 04/25/16
US9120771 46 Azetidine derivative and antidepressant composition including the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 04/25/16
US9120772 6 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases GALDERMA RESEARCH & DEVELOPMENT 04/25/16
US9120780 37 Indole or indazole derivative or salt thereof TAIHO PHARMACEUTICAL CO., LTD. 04/25/16
US9120791 119 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD 04/25/16
US9120797 66 Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds Gruenenthal GmbH 04/25/16
US9120785 12 Pyridyl aminopyridines as Syk inhibitors Merck Sharp & Dohme Corp. 04/25/16
US9120781 7 Selective glycosidase inhibitors and uses thereof Simon Fraser University; Merck Sharp & Dohme Corp.; Alectos Therapeutics Inc. 04/25/16
US9120807 28 Thienopyrimidine compounds Vernalis (R&D) Ltd. 04/25/16
US9120786 14 Triazine carboxamides as sodium channel blockers Purdue Pharma, L.P. 04/25/16
US9115121 70 1,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof Sanofi 04/18/16
US9119845 20 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase Amicus Therapeautics, Inc. 04/18/16
US9115122 39 Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK) UNIVERSITY OF MARYLAND, BALTIMORE 04/18/16
US9120744 43 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN; EASTERN MICHIGAN UNIVERSITY 04/18/16
US9120752 40 Pyridine compounds as sodium channel blockers Purdue Pharma, L.P. 04/18/16
US9120749 650 Quinoline derivatives and MELK inhibitors containing the same ONCOTHERAPY SCIENCE, INC. 04/18/16
US9120761 34 Selective FAK inhibitors Cancer Therapeutics CRC PTY LTD 04/18/16
US9120756 63 Substituted phenylureas and phenylamides as vanilloid receptor ligands Gruenenthal GmbH 04/18/16
US9120745 4 Triazole compounds that modualte HSP90 activity Synta Pharmaceuticals Corp. 04/18/16
US9115089 2 Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds CONFLUENCE LIFE SCIENCES, INC. 04/12/16
US9115140 33 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof SANOFI 04/12/16
US9115126 10 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives Merck Sharp & Dohme B.V. 04/11/16
US9096593 403 Compounds and methods for kinase modulation, and indications therefor Plexxikon Inc. 04/11/16
US9115083 75 Compounds from Antrodia cinnamomea and use thereof SIMPSON BIOTECH CO., LTD. 04/11/16
US9115085 1 Crystalline forms of a prolyl hydroxylase inhibitor FIBROGEN, INC. 04/11/16
US9115082 9 Dipeptidyl-peptidase-IV inhibitors for treatment of type 2 diabetes complex with hypertension TBA 04/11/16
US9115116 27 Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase Academia Sinica; National Taiwan University 04/11/16
US9115144 5 Fused heterocyclic derivative and pharmaceutical use thereof KISSEI PHARMACEUTICAL CO., LTD. 04/11/16
US9115102 45 N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors GALDERMA RESEARCH & DEVELOPMENT 04/11/16
US9115117 280 Substituted piperidine compounds and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV 04/11/16
US9102669 100 Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors Janssen Pharmaceutica NV 04/05/16
US9102686 152 5,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators Janssen Pharmaceutica NV 04/04/16
US9102591 244 Benzamides H. Lundbeck A/S 04/04/16
US9102637 93 Bicyclic thiazole compounds CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER 04/04/16
US9102622 63 Fatty acid amide hydrolase inhibitors University of Connecticut 04/04/16
US9096627 6 Hydroxamic acid derivatives Purdue Pharmaceutical Products L.P. 04/04/16
US9102599 15 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases Bristol-Myers Squibb Company 04/04/16
US9114126 10 Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof THE UNIVERSITY OF TOLEDO 04/04/16
US9115061 17 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH 04/04/16
US9102670 445 Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors KUDOS PHARMACEUTICALS LIMITED 04/04/16
US9102656 12 Use of rosuvastatin lactols as medicaments RedX Pharma Limited 04/04/16
US9096559 134 4-carboxybenzylamino derivatives as histone deacetylase inhibitors Merck Sharp & Dohme Corp. 03/28/16
US9096595 51 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators Actelion Pharmaceuticals Ltd 03/28/16
US9096579 258 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments Boehringer Ingelheim International GmbH 03/28/16
US9238653 54 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; MMV MEDICINES FOR MALARIA VENTURE; UNIVERSITY OF WASHINGTON 03/28/16
US9096601 108 Arylamino purine derivatives, preparation method and pharmaceutical use thereof CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.; Sichuan University 03/28/16
US9096580 5 Benzofuran derivatives for the treatment of hepatitis C Bristol-Myers Squibb Company 03/28/16
US9096589 112 Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 03/28/16
US9096541 28 Inhibition of memapsin 1 cleavage in the treatment of diabetes Oklahoma Medical Research Foundation; Purdue Research Foundation 03/28/16
US9096594 15 Kinase inhibitors and methods of use thereof The Broad Institute, Inc.; The General Hospital Corporation; Dana-Farber Cancer Institute, Inc. 03/28/16
US9096515 36 Methods of using cycloalkylmethylamine derivatives REVIVA PHARMACEUTICALS, INC. 03/28/16
US9096596 332 P2X7 modulators JANSSEN PHARMACEUTICA NV 03/28/16
US9096606 64 Quarternized buprenorphine analogs Purdue Pharma, L.P. 03/28/16
US9096549 46 Selective HDAC3 inhibitors ACETYLON PHARMACEUTICALS, INC. 03/28/16
US9089569 190 1,2,6-substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV 03/21/16
US9090564 130 5-alkynyl-pyridines Boehringer Ingelheim International GmbH 03/21/16
US9090562 334 Aryl- or heteroaryl-substituted benzene compounds Epizyme, Inc. 03/21/16
US9090628 126 Benzoxazepin compounds selective for PI3K P110 delta and methods of use GENENTECH, INC. 03/21/16
US9090657 22 Compound and methods for its production NEUROVIVE PHARMACEUTICAL AB 03/21/16
US9090596 84 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies GALDERMA RESEARCH & DEVELOPMENT 03/21/16
US9090589 25 Specific nNOS inhibitors for the therapy and prevention of human melanoma Northwestern University; The Regents of the University of California 03/21/16
US9090618 172 Substituted benzimidazole-type piperidine compounds and uses thereof Purdue Pharma L.P. 03/21/16
US9085584 356 Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders Boehringer Ingelheim International GmbH 03/21/16
US9090625 9 Therapeutic pyrazolyl thienopyridines THESAN PHARMACEUTICALS, INC. 03/21/16
US9085572 10 4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases Bayer Intellectual Property GmbH 03/16/16
US9085531 117 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Albany Molecular Research, Inc.; Bristol-Myers Squibb Company 03/14/16
US9085555 773 Complement pathway modulators and uses thereof NOVARTIS AG 03/14/16
US9085549 48 Compounds for the treatment of neurodegenerative diseases PROTEOTECH INC 03/14/16
US9079902 124 Heteroaryl sodium channel inhibitors AMGEN INC. 03/14/16
US9085571 30 Nonpeptide HIV-1 protease inhibitors Purdue Research Foundation 03/14/16
US9085576 846 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use AMGEN INC. 03/14/16
US9085540 31 Pyrazinecarboxamide compound Astellas Pharma Inc. 03/14/16
US9079913 185 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN 03/14/16
US9079929 29 Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors Bristol-Myers Squibb Company 03/14/16
US9073940 429 Tricyclic pyrazol amine derivatives MERCK SERONO SA 03/09/16
US9079866 833 Flap modulators JANSSEN PHARMACEUTICA NV 03/07/16
US9079834 11 HIV protease inhibitors Merck Canada Inc. 03/07/16
US9073926 105 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core Boehringer Ingelheim International GmbH 03/07/16
US9073939 7 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof Bayer Intellectual Property GmbH 03/07/16
US9073931 108 Liver X receptor modulators Vitae Pharmaceuticals, Inc. 03/07/16
US9079852 20 NMDA receptor antagonists for neuroprotection Emory University; NeurOp, Inc. 03/07/16
US9073936 8 Organic compounds INTRA-CELLULAR THERAPIES, INC. 03/07/16
US9079880 163 Rho kinase inhibitors Boehringer Ingelheim International GmbH 03/07/16
US9079868 1 Selective glycosidase inhibitors and uses thereof Simon Fraser University 03/07/16
US9079906 27 Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments Sanofi 03/07/16
US9073893 60 3-Oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives as PARP-1 inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 02/29/16
US9073870 181 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use Boehringer Ingelheim International GmbH 02/29/16
US9073917 27 Anti-cancer compound and pharmaceutical composition containing the same SANOFI 02/29/16
US9073925 10 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 02/29/16
US9073881 153 Benzoic acid derivatives HOFFMANN-LA ROCHE INC. 02/29/16
US9073876 335 Flap modulators JANSSEN PHARMACEUTICA NV 02/29/16
US9073882 9 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/29/16
US9073869 37 Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmbH 02/29/16
US9073911 108 Pyrazole derivatives HOFFMANN-LA ROCHE INC. 02/29/16
US9073922 368 Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors AbbVie, Inc. 02/29/16
US9073906 44 Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 02/29/16
US9067924 24 1,4 thiazepines/sulfones as BACE1 and/or BACE2 inhibitors HOFFMANN-LA ROCHE INC. 02/22/16
US9067937 113 1,5-naphthyridine derivatives and MELK inhibitors containing the same OncoTherapy Science, Inc. 02/22/16
US9067931 20 2-heteroaryl carboxamides BAYER INTELLECTUAL PROPERTY GMBH 02/22/16
US9067949 216 Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia Albany Molecular Research, Inc. 02/22/16
US9067922 243 Chemical compounds Pfizer Limited 02/22/16
US9073853 157 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists SANOFI 02/22/16
US9062043 371 Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators SENHWA BIOSCIENCES, INC. 02/22/16
US9073821 60 Hydroxamic acid derivative TAISHO PHARMACEUTICAL CO., LTD; TOYAMA CHEMICAL CO., LTD. 02/22/16
US9067935 114 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators Janssen Pharmaceutica, NV 02/22/16
US9073833 17 Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same Chang Gung University 02/22/16
US9067945 10 Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes Boehringer Ingehleim International GmbH 02/22/16
US9067917 220 1,2,5-substituted benzimidazoles as FLAP modulators Janssen Pharmaceutica NV 02/16/16
US9067871 405 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 02/16/16
US9062066 13 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 02/16/16
US9066954 107 Fused heterocyclic derivatives and methods of use Amgen Inc. 02/16/16
US9067888 20 Inhibitors of protein kinases AstraZeneca AB 02/16/16
US9062070 238 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/16/16
US9062059 20 Pyrimidine PDE10 inhibitors Merck Sharp & Dohme Corp. 02/16/16
US9062078 702 Substituted 7-azabicyles and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV 02/16/16
US9062060 11 Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitors H. Lundbeck A/S 02/16/16
US9067914 241 Tropomyosin-related kinase (TRK) inhibitors Genzyme Corporation 02/16/16
US9061041 6 2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 02/09/16
US9062004 58 Cannabinoid-2 agonists Allergan, Inc. 02/09/16
US9062048 173 Cyclohexyl-azetidinyl antagonists of CCR2 Janssen Pharmaceutica NV 02/09/16
US9062026 89 Fused pyrimidines and substituted quinazolines as inhibitors of p97 Cleave Biosciences, Inc. 02/09/16
US9056859 11 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/09/16
US9061023 2 Management and treatment of benign prostatic hyperplasia CSIR 02/09/16
US9056865 149 Pyridine-2-derivatives as smoothened receptor modulators Pfizer Inc. 02/09/16
US9056863 3 Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof H. Lundbeck A/S 02/09/16
US9062045 143 Triazolopyridine compounds Novartis AG 02/09/16
US9056843 460 Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease NOVARTIS AG 02/09/16
US9056847 4 Activity based probes (ABPs) interacting with glycosidases ACADEMISCH MEDISCH CENTRUM BIJ UNIVERSITEIT VAN AMSTERDAM 01/25/16
US9051313 18 Apoptosis signal-regulating kinase inhibitors Gildead Sciences, Inc. 01/25/16
US9056836 11 Benzomorphan analogs and the use thereof Purdue Pharma L.P. 01/25/16
US9051321 28 Heterocyclic acrylamides and their use as pharmaceuticals FAB PHARMA S.A.S. 01/25/16
US9056857 7 Methods for treating or preventing cancer and neurodegenerative diseases SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 01/25/16
US9056832 152 Pyridine compounds and the users thereof Purdue Pharma L.P. 01/25/16
US9051279 174 Substituted isoquinolinones and quinazolinones Novartis AG 01/25/16
US9051311 173 Sulfamide sodium channel inhibitors AMGEN INC. 01/25/16
US9051280 10 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 01/25/16
US9051329 8 Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 01/25/16
US9108973 73 3,5-disubstituted alkynylbenzene compound and salt thereof Taiho Pharmaceutical Co., Ltd. 01/19/16
US9108978 16 Antimicrobial compounds Monash University; Adelaide Research & Innovation Pty Ltd 01/19/16
US9108983 174 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD 01/19/16
US9108984 2 Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors Incyte Corporation; Incyte Holdings Corporation 01/19/16
US9108950 12 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors Respivert, Ltd. 01/18/16
US9108956 11 Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors NOVARTIS AG 01/18/16
US9051265 89 N-benzylindole modulators of PPARG The Scripps Research Institute 01/18/16
US9051270 160 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 01/18/16
US9051240 7 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators Newron Pharmaceuticals S.P.A. 01/18/16
US9045501 28 5-HT3 receptor modulators, methods of making, and use thereof Albany Molecular Research, Inc. 01/11/16
US9108903 76 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 01/11/16
US9107954 14 Bivalent ligands for the treatment of neurological disorders Virginia Commonwealth University 01/11/16
US9107923 81 Heteroaromatic compounds and their use as dopamine D1 ligands Pfizer Inc. 01/11/16
US9045498 25 Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 01/11/16
US9045500 32 Inhibitors of beta-secretase Vitae Pharmaceuticals, Inc. 01/11/16
US9108947 18 Inhibitors of the Renal Outer Medullary Potassium channel Merck Sharp & Dohme Corp. 01/11/16
US9045524 160 Selective caspase inhibitors and uses thereof NOVAGENESIS FOUNDATION 01/11/16
US9108951 16 Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors Bristol-Myers Squibb Company 01/11/16
US9108905 19 TRPA1 antagonists AbbVie Inc. 01/11/16
US9045468 186 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Albany Molecular Research, Inc.; Bristol-Myers Squibb Company 12/21/15
US9045389 9 Biphenyl derivatives useful as glucagon receptor antagonists Janssen Pharmaceutica NV 12/21/15
US9040694 20 Compounds and methods useful for directing stem cell differentiation Vanderbilt University 12/21/15
US9040693 15 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof KISSEI PHARMACEUTICAL CO., LTD. 12/21/15
US9040727 36 Histone deacetylase inhibitor of benzamides and use thereof Shanghai Institute of Pharmaceutical Industry; Sinopharm A-Think Pharmaceutical Co., Ltd.; Sinopharm A-Think Medical and Pharmaceutical Research & Development (Beijing) Co., Ltd. 12/21/15
US9040691 47 Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors BAYER INTELLECTUAL PROPERTY GMBH 12/21/15
US9040714 139 IRE-1α inhibitors MannKind Corporation 12/21/15
US9045483 13 Inhibition of small ubiquitin-like modifier enzymes with substituted pyrrolo[2,3-b]quinoxalines City of Hope; Sanford-Burnham Medical Research Institute 12/21/15
US9045459 3 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 12/21/15
US9040717 10 Pyrazole-amide compounds and pharmaceutical use thereof JAPAN TOBACCO INC. 12/21/15
US9040518 72 Chemical compounds GlaxoSmithKline LLC 12/14/15
US9040528 203 Chemical compounds 542 AstraZeneca AB 12/14/15
US9040501 5 Compositions and methods for treating cancer Otsuka Pharmaceutical Co., Ltd. 12/14/15
US9040663 202 Melanocortin receptor-specific peptides AstraZeneca AB 12/14/15
US9040509 6 Method of treating human skin and a skin care composition for use in such a method Pantarhei Bioscience B.V. 12/14/15
US9035059 157 Nitrogen-containing condensed heterocyclic compound TAISHO PHARMACEUTICAL CO., LTD. 12/14/15
US9035074 168 Pyrrolo[2,3-D]pyrimidine derivatives Pfizer Inc. 12/14/15
US9040542 2 Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea VERTEX PHARMACEUTICALS INCORPORATED 12/14/15
US9040534 279 [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators Janssen Pharmaceutica NV 12/14/15
US9034921 203 Diphenylmethane derivatives as SGLT2 inhibitors GREEN CROSS CORPORATION 12/08/15
US9035066 3 Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compounds Proximagen Limited 12/08/15
US9035062 3 Process for preparing a compound useful for producing an optically active diazabicyclooctane compound MEIJI SEIKA PHARMA CO., LTD. 12/08/15
US9034856 51 17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative Bayer Intellectual Property GmbH 12/07/15
US9034886 5 4-aminoquinazoline derivatives and uses thereof Shanghai Institute of Pharmaceutical Industry; Jiangsu Hengyi Pharmaceutical Co., Ltd. 12/07/15
US9034574 20 Agents for reversing epigenetic silencing of genes The Johns Hopkins University 12/07/15
US9034899 81 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof Albany Molecular Research, Inc. 12/07/15
US9034874 20 Carbamate/urea derivatives NOVARTIS AG 12/07/15
US9034897 44 Indanyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them SANOFI 12/07/15
US9034907 36 Inhibitors of glutaminyl cyclase Probiodrug AG 12/07/15
US9034866 815 Tricyclic compounds and methods of use therefor Genentech, Inc. 12/07/15
US9029399 54 17α-hydroxylase/C17,20-lyase inhibitors Novartis AG 11/23/15
US9029364 34 2,5-disubstituted thiomorpholine orexin receptor antagonists Merck Sharp & Dohme Corp. 11/23/15
US9029393 22 Adenosine receptor ligands and uses thereof Kaldi Pharma, SAS 11/23/15
US9029381 55 Cyclopropyl amide derivatives Astrazeneca AB 11/23/15
US9029362 23 Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 11/23/15
US9034303 10 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof TBA 11/23/15
US9034854 6 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy PANTARHEI BIOSCIENCE B.V. 11/23/15
US9029401 58 Sorafenib derivatives as sEH inhibitors The Regents of the University of California 11/23/15
US9029370 276 Substituted benzamide derivatives Hoffmann-La Roche Inc. 11/23/15
US9023767 2 γ-Secretase substrates and methods of use Memorial Sloan-Kettering Cancer Center 11/16/15
US9023882 212 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same Kissei Pharmaceutical Co., Ltd. 11/16/15
US9029367 5 BACE inhibitors Eli Lilly and Company 11/16/15
US9023865 687 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/16/15
US9024044 162 Heteroarylcarboxylic acid ester derivative Ajinomoto Co., Inc. 11/16/15
US9029360 36 Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists Boehringer Ingelheim International GmbH 11/16/15
US9023849 22 Substituted fused imidazoles and pyrazoles and use thereof Bayer Intellectual Property GmbH 11/16/15
US9029356 12 Substituted indazole derivatives active as kinase inhibitors Nerviano Medical Sciences S.R.L. 11/16/15
US9018371 27 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient FM Therapeutics Co., Ltd.; The United States of America, As Represented by the Secretary, Department of Health and Human Services, The Office of Technology Transfer, National Institutes of Health 11/11/15
US9018381 66 Chemical compounds AstraZeneca AB 11/11/15
US9023354 43 Combination therapy with MDM2 and EFGR inhibitors TBA 11/11/15
US9018217 124 Phenylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 11/11/15
US9029559 503 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals SANOFI 11/11/15
US9018213 12 Alicyclic[c] benzopyrone derivatives and uses thereof Huazhong University of Science & Technology; NHWA Pharma. Corporation 11/02/15
US9018214 370 Bicyclic heterocycle compounds and their uses in therapy Astex Therapeutics Limited 11/02/15
US9011882 20 Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof The Board of Trustees of the Leland Stanford Junior University 11/02/15
US9018255 7 Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin—thioredoxin reductase system Instytut Chemii Organicznej Polskiej Akademii Nauk; Warszawski Uniwersytet Medyczny 11/02/15
US9012461 132 FAK inhibitors Cancer Therapeutics CRC Pty Ltd 11/02/15
US9018234 8 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof Bayer Intellectual Property GmbH 11/02/15
US9018391 16 Inhibitors of beta-secretase Boehringer Ingelheim International GmbH; Vitae Pharmaceuticals, Inc. 11/02/15
US9018211 9 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 11/02/15
US9012475 26 Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor Taiho Pharmaceutical Co., Ltd. 11/02/15
US9012651 291 TRPV3 modulators AbbVie Inc. 11/02/15
US9006269 19 Azetidine derivatives Vernalis (R&D) Ltd. 10/26/15
US9006454 111 Dihydroorotate dehydrogenase inhibitors Merck Serono S.A. 10/26/15
US9006244 14 Liver X receptor modulators Vitae Pharmaceuticals, Inc. 10/26/15
US9006283 6 Methods of modifying amyloid β oligomers using non-peptidic compounds Acumen Pharmaceuticals, Inc. 10/26/15
US9006268 10 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp. 10/26/15
US9006232 98 Pyrimidone derivatives Mitsubishi Tanabe Pharma Corporation 10/26/15
US9006282 20 Rosuvastatin and atorvastatin derivatives Redx Pharma Limited 10/26/15
US9006249 13 Substituted aminobutyric derivatives as neprilysin inhibitors Novartis AG 10/26/15
US9006242 15 Substituted benzene compounds Epizyme, Inc. 10/26/15
US9006246 15 Tetrahydrocarboline derivative Ono Pharmaceutical Co., Ltd. 10/26/15
US9000182 41 2H-imidazol-4-amine compounds and their use as BACE inhibitors AstraZeneca AB 10/19/15
US9000185 18 Cycloalkyl ether compounds and their use as BACE inhibitors AstraZeneca AB 10/19/15
US9000183 21 Cyclohexane-1,2′-indene-1′,2″-imidazol compounds and their use as BACE inhibitors Astrazeneca AB 10/19/15
US9000184 31 Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitors AstraZeneca AB 10/19/15
US8999957 459 Heterocyclic compounds as ERK inhibitors Merck Sharp & Dohme Corp. 10/19/15
US9000153 43 Imidazo[4,5-c]quinolines as DNA-PK inhibitors Merck Patent GmbH 10/19/15
US9000043 4 Phenoxyethoxy compounds Eli Lilly and Company 10/19/15
US9000029 118 Proline sulfonamide derivatives as orexin receptor antagonists Actelion Pharmaceuticals Ltd. 10/19/15
US9000044 67 Substituted naphthylacetic acids Hoffmann-La Roche Inc. 10/19/15
US9006187 34 Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising same Green Cross Corporation 10/19/15
US8999981 252 3-amido-pyrrolo[3,4-C]pyrazole-5(1H, 4H,6H) carbaldehyde derivatives Pfizer Inc.; Pfizer Products Inc. 10/12/15
US9012443 827 Bicyclic aryl and heteroaryl sodium channel inhibitors Amgen Inc. 10/12/15
US9000008 5 Amides of acetic and propionic acids Bayer Intellectual Property GmbH 10/05/15
US9000015 42 Compounds for the treatment of addiction Gilead Sciences, Inc. 10/05/15
US8999994 36 Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases Consejo Superior de Investigaciones Cientificas; Universitat Autonoma de Barcelona; Universidad de Barcelona 10/05/15
US8999980 19 Oxazine derivatives Shionogi & Co., Ltd. 10/05/15
US8999982 16 Pharmaceutically active compounds as Axl inhibitors Lead Discovery Center GmbH; Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V. 10/05/15
US8993808 181 Phenylcyclopropylamine derivatives and their medical use Oryzon Genomics, S.A. 10/05/15
US8999998 95 Pyrazolopyrimidine JAK inhibitor compounds and methods Genentech, Inc. 10/05/15
US8999975 140 Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C Boehringer Ingelheim International GmbH 10/05/15
US8999955 14 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological Centre National de la Recherche Scientifique 10/05/15
US8993616 113 (aza)indole derivative and use thereof for medical purposes Kissei Pharmaceutical Co., Ltd. 09/28/15
US8993596 3 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics Galderma Research & Development 09/28/15
US8993631 43 Method of treating contrast-induced nephropathy Novartis AG 09/28/15
US8993612 10 Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer Rhizen Pharmaceuticals SA 09/28/15
US8993568 6 Morpholinyl derivatives useful as MOGAT-2 inhibitors Eli Lilly and Company 09/28/15
US8993586 248 N1/N2-lactam acetyl-CoA carboxylase inhibitors Pfizer Inc. 09/28/15
US8993756 226 Pyrrolopyrimidines as janus kinase inhibitors Merck Sharp & Dohme Corp. 09/28/15
US8993614 52 Substituted pyrrolidine-2-carboxamides F. Hoffmann-La Roche AG 09/28/15
US8993765 26 Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof Albany Molecular Research, Inc. 09/28/15
US8993575 12 [1,3,4] oxadiazole derivative and application thereof Huazhong University of Science & Technology; NHWA Pharma Corporation 09/28/15
US8993565 161 (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors Sanofi 09/03/15
US8993552 72 Compositions and methods for treatment of leukemia The Regents of The University of Michigan; University of Virginia Patent Foundation 09/03/15
US8987474 133 Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogs University of South Florida; H. Lee Moffitt Cancer Center and Research Institute, Inc. 09/03/15
US8993557 10 Pyridinedione carboxamide inhibitors of endothelial lipase Bristol-Myers Squibb Company 09/03/15
US8993556 18 Resorcinol derivatives as HSP90 inhibitors Nerviano Medical Sciences S.R.L. 09/03/15
US8987473 72 Ring-fused compound Sato Pharmaceutical Co., Ltd. 09/03/15
US8987457 595 Ring-substituted N-pyridinyl amides as kinase inhibitors Novartis AG 09/03/15
US8987319 37 Selective androgen receptor modulators Radius Health, Inc. 09/03/15
US8987335 35 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors University of Utah Research Foundation 09/03/15
US8987445 181 Sulfonamide compounds having TRPM8 antagonistic activity Mitsubishi Tanabe Pharma Corporation 09/03/15
US8987314 725 Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 08/25/15
US8987272 3 Compounds and method for treatment of HIV Critical Outcome Technologies Inc. 08/25/15
US8987257 68 Heterocyclic derivatives Novartis AG 08/25/15
US8987313 34 Inhibitors of cytochrome P450 Gilead Sciences, Inc. 08/25/15
US8987315 20 Metalloenzyme inhibitor compounds Innocrin Pharmaceuticals, Inc. 08/25/15
US8981106 177 Pyrimidinecarboxamides as CXCR2 modulators Syntrix Biosystems, Inc. 08/25/15
US8987268 121 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Bristol-Myers Squibb Company 08/25/15
US8987287 25 Spirocyclic morphinans and their use Purdue Pharma L.P. 08/25/15
US8987273 75 Substituted imidazo[1,2-B]pyridazines Bayer Intellectual Property GmbH 08/25/15
US8987286 45 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the Pi3K/Akt pathway Bayer Intellectual Property GmbH 08/25/15
US8987239 20 19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives Bayer Intellectual Property GbmH 08/19/15
US8980938 7 CXCR2 inhibitors Sanofi 08/19/15
US8980932 40 Cancer targeting using carbonic anhydrase isoform IX inhibitors Stichting Maastricht Radiation Oncology “Maastro-Clinic”; Université Montpellier 2 Sciences et Techniques 08/19/15
US8981112 25 Inhibitors of β-secretase Vitae Pharmaceuticals, Inc.; Boehringer-Ingelheim International GmbH 08/19/15
US8987247 3 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders Janssen Pharmaceutica NV 08/19/15
US8987242 15 Morpholinone compounds as factor IXA inhibitors Merck Sharp & Dohme Corp.; Mochida Pharmaceuticals Co., Ltd. 08/19/15
US8987249 358 Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C Boehringer Ingelheim International GmbH 08/19/15
US8980954 13 Substituted cis- and trans-stilbenes as therapeutic agents STC.UNM 08/19/15
US8987248 26 Substituted piperidines as Par-1 antagonists Bayer Intellectual Property GmbH 08/19/15
US8987254 8 Tetrahydropyrrolothiazine compounds Eli Lilly and Company 08/19/15
US8980887 7 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof Institute of Pharmacology; Toxicology Academy of Military Medical Sciences P.L.A., China 08/10/15
US8980901 5 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta Icos Corporation 08/10/15
US8980829 56 Aryl glycoside compound, preparation method and use thereof Shanghai Yingli Science and Technology Co., Ltd; Shanghai Chempartner Co., Ltd 08/10/15
US8980905 10 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors Leo Pharma A/S 08/10/15
US8975415 367 Chromane compounds CoMentis, Inc. 08/10/15
US8980916 3 Factor IXa inhibitors Merck Sharp & Dohme Corp.; Mochida Pharmaceutical Co., Ltd. 08/10/15
US8980904 18 Heterocyclic substituted pyrimidine compound Xuanzhu Pharma Co., Ltd. 08/10/15
US8975409 18 Phenyl derivative ONO Pharmaceutical Co., Ltd. 08/10/15
US8975417 716 Pyrazolopyrrolidine derivatives and their use in the treatment of disease Novartis AG 08/10/15
US8980906 50 Pyridonemorphinan analogs and biological activity on opioid receptors Purdue Pharma L.P. 08/10/15
US8980929 14 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp. 08/10/15
US8975250 13 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases SANOFI 08/03/15
US8975261 14 Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors Merck Sharp & Dohme Corp. 08/03/15
US8975249 94 Heterocyclic compounds and uses thereof Celgene Avilomics Research, Inc. 08/03/15
US8975276 8 Inhibitors of PDE10 Bristol-Myers Squibb Company 08/03/15
US8962860 19 Inhibitors of glutaminyl cyclase Probiodrug AG 08/03/15
US8975247 27 Methods and compositions of treating a flaviviridae family viral infection The Board of Trustees of the Leland Stanford Junion University 08/03/15
US8975252 2 Morpholine derivative Shanghai Pharmaceuticals Holding Co., Ltd.; Mitsubishi Tanabe Pharma Corporation 08/03/15
US8975260 12 Pyridazinones, method of making, and method of use thereof Genetech, Inc; Gilead Connecticut, Inc. 08/03/15
US8975265 371 Substituted imidazo[1,2-a]pyrimidines and —pyridines Bayer Intellectual Property GmbH 08/03/15
US8975282 8 Substituted pyrazolone compounds and methods of use Sunshine Lake Pharma Co., Ltd.; Calitor Sciences, LLC 08/03/15
US8975267 51 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.r.l. 08/03/15
US8962637 76 Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors Debiopharm S.A.; Aurigene Discovery Technologies Ltd. 07/22/15
US8962651 8 Compounds for the treatment of hepatitis C Bristol-Myers Squibb Company 07/22/15
US8962674 93 Curcumin derivative Tokyo Institute of Technology; Kyoto University 07/22/15
US8962837 24 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics Pierre Fabre Medicament 07/22/15
US8962646 38 Peripherally acting opioid compounds Alkermes, Inc. 07/22/15
US8962659 4 Phenoxyethyl piperidine compounds Eli Lilly and Company 07/22/15
US8962641 490 Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 07/22/15
US8962630 205 Pyrrolopyrimidine compounds and their uses Novartis AG 07/22/15
US8962664 3 Selective glycosidase inhibitors and uses thereof Simon Fraser University 07/22/15
US8962859 12 Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use Amgen Inc. 07/22/15
US8962648 231 Tricyclic compounds and PBK inhibitors containing the same OncoTherapy Science, Inc. 07/22/15
US8957084 9 7,8-cyclicmorphinan analogs Purdue Pharma L.P. 07/15/15
US8957219 12 Acetic acid amide derivative having inhibitory activity on endothelial lipase Shionogi & Co., Ltd. 07/15/15
US8957103 18 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment Johannes Gutenberg—Universitat Mainz 07/15/15
US8962608 1192 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors Merck Sharp & Dohme Corp. 07/15/15
US8962616 41 Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 07/15/15
US8957093 262 N-biphenylmethylindole modulators of PPARG The Scripps Research Institute 07/15/15
US8962609 129 Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them Domainex Limited 07/15/15
US8962611 356 Substituted imidazopyridines as HDM2 inhibitors Merck Sharp & Dohme Corp. 07/15/15
US8962619 36 Substituted imidazopyridinyl-aminopyridine compounds ArQule, Inc. 07/15/15
US8962612 20 Tetrahydroisoquinoline derivative Astellas Pharma Inc. 07/15/15
US8957075 28 O-GlcNAc transferase inhibitors and uses thereof President and Fellows of Harvard College 07/10/15
US8957077 14 Pyrazolopyrimidine PDE 10 inhibitors Merck Sharp & Dohme Corp. 07/10/15
US8957074 298 Pyrrolopyrimidine compounds as inhibitors of CDK4/6 Novartis AG 07/10/15
US8957083 31 Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use Amgen Inc. 07/10/15
US8957068 870 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Novartis AG 07/09/15
US8957064 185 Fused pyrimidines Bayer Intellectual Property GmbH 07/09/15
US8957059 66 Modulators of serotonin receptors Janssen Pharmaceutica NV 07/09/15
US8957073 378 Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors Amgen Inc. 07/09/15
US8957057 4 Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor Food Industry Research and Development Institute 07/09/15
US8952177 191 1,2,6-substituted benzimidazoles as FLAP modulators Janssen Pharmaceutica NV 06/29/15
US8952157 407 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research 06/29/15
US8952036 5 Benzoic acid derivative MDM2 inhibitor for the treatment of cancer Amgen Inc. 06/29/15
US8952037 98 Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors Amgen Inc. 06/29/15
US8956589 22 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases Shiga University of Medical Science 06/29/15
US8952027 12 Inhibitors of syk and JAK protein kinases Portola Pharmaceuticals, Inc. 06/29/15
US8952025 3 Multifunctional radical quenchers and their uses Arizona Board of Regents, A Body Corporate of the State of Arizona Acting for and on Behalf of Arizona State University 06/29/15
US8952169 708 N-substituted benzamides and methods of use thereof Xenon Pharmaceuticals Inc.; Genentech, Inc. 06/29/15
US8952150 30 Prostaglandin transporter inhibitors and uses thereof Albert Einstein College of Medicine of Yeshiva University 06/29/15
US8952128 168 Somatostatin-dopamine chimeric analogs Ipsen Pharma S.A.S. 06/29/15
US8969583 55 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors Allergan, Inc. 06/22/15
US8952002 3 Aminoheteroaryl compounds and preparation method and use thereof Shanghai Allist Pharmaceuticals, Inc. 06/22/15
US8969358 54 Buprenorphine analogs Purdue Pharma L.P. 06/22/15
US8952008 50 Chemical compounds Pfizer Limited 06/22/15
US8969348 10 Chymase inhibitors Boehringer Ingelheim International GmbH 06/22/15
US8969336 95 Diamino heterocyclic carboxamide compound Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd. 06/22/15
US8969578 13 Inhibitors of STAT3 University of Central Florida Research Foundation, Inc. 06/22/15
US8969376 43 Pyrazolopyrimidine compounds and their use as PDE10 inhibitors Mitsubishi Tanabe Pharma Corporation 06/22/15
US8969586 18 Substituted bicyclic heteroaryl compounds Bristol-Myers Squibb Company 06/22/15
US8969568 125 Substituted naphthyridines and their use as medicaments Boehringer Ingelheim Pharma GmbH & Co. KG 06/22/15
US8969333 6 Therapeutic compositions and methods The Penn State Research Foundation 06/22/15
US8969394 24 Thiophenecarboxamide derivatives as EP4 receptor ligands Merck Frosst Canada Ltd. 06/22/15
US8969335 189 Benzonitrile derivatives as kinase inhibitors MERCK PATENT GmbH 06/16/15
US8940739 190 Compound of a reverse-turn mimetic and a production method and use therefor JW Pharmaceutical Corporation 06/16/15
US8940893 17 Heteroaromatic compounds as BTK inhibitors Boehringer Ingelheim International GmbH 06/16/15
US8940748 21 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 06/16/15
US8940720 77 Macrocycles as factor XIa inhibitors Bristol-Myers Squibb Company 06/16/15
US8940771 29 Organic compounds Novartis AG 06/16/15
US8940744 33 Pyrazolopyrimidine compounds as kinase inhibitors Principia Biopharma Inc. 06/16/15
US8969341 345 Pyrazolopyrrolidine compounds Novartis AG 06/16/15
US8969352 164 Substituted 2-azabicycles and their use as orexin receptor modulators Janssen Pharmaceutica NV 06/16/15
US8969325 333 TRPV1 antagonists AbbVie Inc. 06/16/15
US8937070 24 Inhibitors of protein kinases Portola Pharmaceuticals, Inc. 06/15/15
US8937058 38 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative TBA 06/08/15
US8937095 12 Anticancer compounds Boehringer Ingelheim International GmbH 06/08/15
US8937193 50 Apogossypolone derivatives as anticancer agents Sanford-Burnham Medical Research Institute 06/08/15
US8937092 22 Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands Gruenenthal GmbH 06/08/15
US8940736 142 Imidazotriazinecarbonitriles useful as kinase inhibitors Bristol-Myers Squibb Company 06/08/15
US8940719 16 Lithocholic acid analogues that inhibit sialyltransferase Academia Sinica 06/08/15
US8937084 27 Nitrogen containing morphinan derivatives and the use thereof Purdue Pharma L.P. 06/08/15
US8937068 220 Pyridopyrazine derivatives and their use Zentaris GmbH 06/08/15
US8940738 11 Pyrimidone compounds Mitsubishi Tanabe Pharma Corporation 06/08/15
US8933228 147 Respiratory formulations and compounds for use therein Respivert, Ltd. 06/08/15
US8933224 248 Triazine derivatives Pfizer Inc. 06/08/15
US8927738 26 2-arylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 06/01/15
US8933024 22 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases Sanofi 06/01/15
US8933098 4 Dimethyl-benzoic acid compounds Eli Lilly and Company 06/01/15
US8933221 31 Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 06/01/15
US8927730 16 Intramolecular hydrogen-bonded nitric oxide synthase inhibitors Northwestern University 06/01/15
US8933095 29 KAT II inhibitors Pfizer Inc. 06/01/15
US8927563 4 Kinase inhibitor Respivert Limited; Topivert Pharma Limited 06/01/15
US8933099 139 Monocyclic pyridine derivative Eisai R&D Management Co., Ltd. 06/01/15
US8933079 121 Pyridone and pyridazinone derivatives as anti-obesity agents Boehringer Ingelheim International GmbH 06/01/15
US8927577 27 Quinolinyl glucagon receptor modulators Pfizer Inc. 06/01/15
US8933040 7 Selective glycosidase inhibitors and uses thereof TBA 06/01/15
US8933056 55 Soft protease inhibitors and pro-soft forms thereof Trustees of Tufts College 06/01/15
US8921559 61 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2 Janssen Pharmaceutica NV 05/26/15
US8927520 6 Antibacterial compounds Institut Pasteur; Institut Curie 05/26/15
US8921397 263 Benzofurane-piperidine compounds Hoffmann-La Roche Inc. 05/26/15
US8921412 16 C-aryl ansa SGLT2 inhibitors Green Cross Corporation 05/26/15
US8927534 24 Compounds for the inhibition of integrins and use thereof Shire Orphan Therapies GmbH 05/26/15
US8927539 10 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure Vitae Pharmaceuticals, Inc. 05/26/15
US8921424 13 Histone deacetylase inhibitors, process for preparation and uses thereof Zhejiang Hisun Pharmaceutical Co. Ltd.; Central South University 05/26/15
US8921421 2 Inhibitors of dimethylarginine dimethylaminohydrolase Christian-Albrechts-Universitaet Zu Kiel 05/26/15
US8921389 217 Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase Fibrogen, Inc. 05/26/15
US8921410 175 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes Targacept, Inc. 05/26/15
US8927507 8 Selective glycosidase inhibitors and uses thereof TBA 05/26/15
US8927536 14 Tetrahydrothiazepine derivative Daiichi Sankyo Company, Limited 05/26/15
US8653304 10 2,3-dihydro-1H-indene-2-yl urea derivative and pharmaceutical application of same Toray Industries, Inc. 05/18/15
US8916594 27 5-membered ring heteroaromatic derivatives having NPY Y5 receptor antagonistic activity Shionogi & Co., Ltd. 05/18/15
US8921404 9 Azole derivatives in the form of lipase and phospholipase inhibitors Sanofi 05/18/15
US8921370 20 Bicyclo[3.2.1]octyl amide derivatives and uses of same H. Lundbeck A/S 05/18/15
US8921373 25 Compounds having TRPV1 antagonistic activity and uses thereof Shionogi & Co., Ltd. 05/18/15
US8653257 5 Dibenzothiazepine derivatives and uses thereof—424 Astrazeneca AB 05/18/15
US8921364 56 Modulators of calcium release-activated calcium channel Rhizen Pharmaceuticals SA 05/18/15
US8916600 20 Phenyl and benzodioxinyl substituted indazoles derivatives Astrazeneca AB; Bayer Pharma Aktiengesellschaft 05/18/15
US8921368 103 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Bristol-Myers Squibb Company 05/18/15
US8921319 60 Serine protease inhibitors The Medicines Company (Leipzig) GmbH 05/18/15
US8653100 267 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 05/18/15
US8916577 22 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.R.L. 05/18/15
US8912208 4 (4-{4-[5-(benzooxazol-2-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid useful for treating or preventing conditions or disorders associated with DGAT1 activity Novartis AG 05/11/15
US8916574 6 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors Qilu Pharmaceutical Co., Ltd. 05/11/15
US8912219 10 Aryl sulfamide and sulfamate derivatives as RORc modulators Genentech, Inc. 05/11/15
US8912221 44 Biaryl amide derivatives Hoffmann-La Roche Inc. 05/11/15
US8912181 115 Bicyclic compound or salt thereof Taiho Pharmaceutical Co., Ltd. 05/11/15
US8907086 8 Fused bicyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 05/11/15
US8916576 100 Pharmacokinetically improved compounds Surface Logix, Inc. 05/11/15
US8912224 390 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals Sanofi 05/11/15
US8912173 121 Substituted quinolines and their use as medicaments Boehringer Ingelheim International GmbH 05/11/15
US8916553 45 Sulfonamide compounds useful as CYP17 inhibitors Bristol-Myers Squibb Company 05/11/15
US8912213 12 Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (TDP1)- topoisomerase I (TOP1) inhibitors Purdue Research Foundation 05/11/15
US8906943 19 Synthetic compounds and methods to decrease nicotine self-administration TBA 05/11/15
US8895581 96 1H-imidazo[4,5-c]quinolines Boehringer Ingelheim International GmbH 05/04/15
US8901140 7 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. 05/04/15
US8895745 17 Bicyclic heterocyclic compounds as FGFR inhibitors Astex Therapeutics Limited 05/04/15
US8906911 68 Chemokine receptor antagonists AbbVie Inc. 05/04/15
US8895592 76 Compounds as cannabinoid receptor ligands AbbVie Inc. 05/04/15
US8901115 25 Cyclic P1 linkers as factor XIa inhibitors Bristol-Myers Squibb Company 05/04/15
US8906933 30 Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists N30 Pharmaceuticals, Inc. 05/04/15
US8901295 31 Inhibitors of cyclophilins and uses thereof Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Montpellier 1; Universite Paris-EST Creteil val de Marne; Assistance Publique-Hopitaux de Paris; Centre National de la Recherche Scientifique 05/04/15
US8901087 39 Selective glycosidase inhibitors and uses thereof Merck Sharp & Dohme Corp. 05/04/15
US8901315 337 Thienopyrazole derivative having PDE7 inhibitory activity Daiichi Sankyo Company, Limited 05/04/15
US8901310 29 Tricyclic compounds, compositions, and methods Pfizer Inc. 05/04/15
US8614223 561 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof Acetylon Pharmaceuticals, Inc. 05/03/15
US8895549 35 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Bayer Intellectual Property GmbH 04/27/15
US8889684 10 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors Boehringer Ingelheim International GmbH 04/27/15
US8889671 80 Compounds and methods for treating bacterial infections AstraZeneca AB 04/27/15
US8889672 29 Compounds, formulations, and methods of protein kinase C inhibition The Regents of The University of Michigan; The Penn State Research Foundation 04/27/15
US8614195 22 Glycoside derivatives and uses thereof Novartis AG 04/27/15
US8895544 57 Indazoles Pfizer Limited 04/27/15
US8895245 10 Inhibitors of human EZH2 and methods of use thereof Epizyme, Inc. 04/27/15
US8889870 111 Kinase inhibitors Allergan, Inc. 04/27/15
US8894989 59 PARP inhibitor compounds, compositions and methods of use Eisai Inc. 04/27/15
US8889708 42 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmbH 04/27/15
US8889696 65 Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof Temple University—Of The Commonwealth System Of Higher Education 04/27/15
US8889724 7 Tetrazole compounds for reducing uric acid Wellstat Therapeutics Corporation 04/27/15
US8877733 2 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment Gilead Sciences, Inc. 04/20/15
US8884017 21 2-heteroarylcarboxylic acid amides Bayer Intellectual Property GmbH 04/20/15
US8883759 20 Anti-tumor effect potentiator Taiho Pharmaceutical Co., Ltd. 04/20/15
US8883784 15 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc. 04/20/15
US8883771 150 Bivalent inhibitors of IAP proteins and therapeutic methods using the same The Regents of the University of Michigan 04/20/15
US8614213 83 Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists Novartis AG 04/20/15
US8883797 12 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 04/20/15
US8889668 31 Oxadiazole diaryl compounds Merck Serono SA 04/20/15
US8877741 485 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 04/20/15
US8614220 15 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.r.l. 04/20/15
US8883846 5 Synthesis of bicyclic compounds and method for their use as therapeutic agents UVic Industry Partnerships Inc. 04/20/15
US8877798 71 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders Neurovance, Inc. 04/13/15
US8877944 96 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors Nerviano Medical Sciences S.R.L. 04/13/15
US8877778 285 Benzofurane compounds Hoffmann-La Roche Inc. 04/13/15
US8877967 42 Compositions and methods for inhibition of cathepsins OXiGENE, Inc.; Baylor University 04/13/15
US8871738 76 Fused bicyclic oxazolidinone CETP inhibitor Merck Sharp & Dohme Corp. 04/13/15
US8877795 33 Identification of stabilizers of multimeric proteins The Board of Trustees of the Leland Stanford Junior University 04/13/15
US8877791 8 Inhibitors of pyruvate kinase and methods of treating disease Beth Israel Deaconess Medical Center, Inc. 04/13/15
US8871728 49 Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof Georgia Tech Research Corporation 04/13/15
US8877757 7 Pyrazine derivatives and use as PI3K inhibitors Merck Serono SA 04/13/15
US8877775 37 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmbH 04/13/15
US8877786 7 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors Novartis AG 04/13/15
US8871778 44 Substituted pyrimidine compounds and their use as SYK inhibitors Genosco; Oscotec, Inc. 04/13/15
US8865911 180 Compounds and their use as BACE inhibitors Astrazeneca AB 04/06/15
US8865655 4 Depsipeptides and their therapeutic use Karus Therapeutics Limited 04/06/15
US8871934 680 Fluorene compound and pharmaceutical use thereof Japan Tobacco Inc. 04/06/15
US8865706 30 Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 04/06/15
US8871790 475 Heterocyclic modulators of lipid synthesis 3-V Biosciences, Inc. 04/06/15
US8865662 5 Macrolides and their use Basilea Pharmaceutica AG 04/06/15
US8865698 105 Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds Array BioPharma Inc. 04/06/15
US8865714 35 Piperazine compound capable of inhibiting prostaglandin D synthase Taiho Pharmaceutical Co., Ltd. 04/06/15
US8865701 11 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease Merck Sharp & Dohme Corp. 04/06/15
US8871783 26 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmBh 04/06/15
US8865726 144 Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors Array BioPharma Inc. 04/06/15
US8865686 8 Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors The United States of America, as Represented by the Secretary, Dept. of Health and Human Services 04/06/15
US8859534 106 2-carboxamide-7-piperazinyl-benzofuran derivatives Acturum Life Science AB 03/16/15
US8853224 62 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases Industrial Research Limited; Albert Einstein College of Medicine of Yeshiva University 03/16/15
US8859596 128 Compounds as cannabinoid receptor ligands AbbVie Inc. 03/16/15
US8859586 50 Cyclohexyl isoquinolinone compounds Novartis AG 03/16/15
US8853215 17 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes Takeda Pharmaceutical Company Limited 03/16/15
US8853203 366 Diazepinone derivatives Novartis AG 03/16/15
US8853227 9 Methotrexate adjuvants to reduce toxicity and methods for using the same Tosk, Incorporated 03/16/15
US8865750 10 Small molecule inhibitors of RGS proteins The Regents of The University of Michigan; The University of Bath 03/16/15
US8853212 17 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp 03/16/15
US8853193 170 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions Boehringer Ingelheim International GmbH 03/16/15
US8853206 11 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments Sanofi 03/16/15
US8853226 26 Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors High Point Pharmaceuticals, LLC 03/16/15
US8853258 197 C-linked hydroxamic acid derivatives useful as antibacterial agents Pfizer Inc. 03/09/15
US8853228 67 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase University of Connecticut 03/09/15
US8853207 12 Heterocyclic pyrazole compounds, method for preparing the same and use thereof Development Center for Biotechnology 03/09/15
US8846601 142 Melanocortin receptor-specific peptides Palatin Technologies, Inc. 03/09/15
US8853242 18 Nitrogenous-ring acylguanidine derivative Astellas Pharma Inc. 03/09/15
US8846658 184 Oxazine derivatives and their use in the treatment of neurological disorders Novartis AG 03/09/15
US8846698 511 Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors Pfizer Limited 03/09/15
US8846000 35 Radiolabeled PDE10 inhibitors Merck Sharp & Dohme Corp. 03/09/15
US8846657 356 Substituted imidazopyridines as HDM2 inhibitors Merck Sharp & Dohme Corp. 03/09/15
US8846656 146 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators Novartis AG 03/09/15
US8846654 11 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives Sanofi 03/09/15
US8846673 38 Azaindazoles as kinase inhibitors and use thereof Bristol-Myers Squibb Company 03/03/15
US8846730 132 Compounds as cannabinoid receptor ligands AbbVie Inc. 03/03/15
US8846711 28 Heterocyclic acrylamides and their use as pharmaceuticals Fab Pharma S.A.S. 03/03/15
US8846719 372 Isoxazolo-pyridine derivatives Roche Palo Alto LLC 03/03/15
US8846741 9 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 03/03/15
US8846696 60 Purine derivatives Cyclacel Limited; Cancer Research Technology Limited 03/03/15
US8846746 520 Pyrazole compound and pharmaceutical use thereof Japan Tobacco Inc. 03/03/15
US8846699 346 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof Hanmi Pharm. Co., Ltd. 03/03/15
US8846660 29 Seven-membered ring compound and pharmaceutical use therefor Daiichi Sankyo Company, Ltd. 03/03/15
US8846689 212 Substituted pyrimidines for the treatment of diseases such as cancer Boehringer Ingelheim International GmbH 03/03/15
US8846929 836 Substituted-quinoxaline-type piperidine compounds and the uses thereof Purdue Pharma L.P.; Shionogi & Co., Ltd. 03/03/15
US8835436 169 Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same Green Cross Corporation 02/23/15
US8841450 2 Compounds useful as inhibitors of ATR kinase Vertex Pharmaceuticals Incorporated 02/23/15
US8846917 1 Compounds useful as inhibitors of ATR kinase Vertex Pharmaceuticals Incorporated 02/23/15
US8835444 36 Cyclohexyl amide derivatives as CRF receptor antagonists Novartis AG 02/23/15
US8835445 82 Dihydrofolate reductase inhibitors Trius Therapeutics, Inc. 02/23/15
US8841312 749 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors Amgen Inc. 02/23/15
US8841453 36 Hybrid cholinesterase inhibitors Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego 02/23/15
USRE45173 173 Inhibitors of CYP 17 Novartis AG 02/23/15
US8841288 10 Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases Universtà Degli Studi di Torino; Università Degli Studi del Piemonte Orientale “Amedeo Avogadro” 02/23/15
US8841455 165 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Array BioPharma Inc. 02/23/15
US8835464 53 Triazole compounds that modulate HSP90 activity Synta Pharmaceuticals Corp. 02/23/15
US8835472 664 Compounds, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 02/16/15
US8828983 13 Macrocycles as factor XIa inhibitors Bristol-Myers Squibb Company 02/16/15
US8835470 25 Mandelamide heterocyclic compounds Bristol-Myers Squibb Company 02/16/15
US8829193 162 PIM kinase inhibitors and methods of their use Novartis AG 02/16/15
US8835659 7 Polysubstituted benzofurans and medicinal applications thereof Ikerchem, S.L.; Universidad del Pais Vasco 02/16/15
US8829010 57 Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors Pfizer Inc. 02/16/15
US8835465 3 Pyrazolylaminopyridine derivatives useful as kinase inhibitors AstraZeneca AB 02/16/15
US8829009 6 Substituted 2-amino-3-(sulfonyl)pyrazolo[1,5-a]pyrimidines - serotonin 5-HT6 receptor antagonists, method for use thereof TBA 02/16/15
US8829000 22 Substituted imidazo[1,5-A]quinoxalines as phosphodiesterase 9 inhibitors ASKA Pharmaceutical Co., Ltd. 02/16/15
US8829190 28 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases Leo Pharma A/S 02/16/15
US8822479 7 6-cyclylmethyl-and 6-alkylmethyl-substituted pyrazolepyrimidines Boehringer Ingelheim International GmbH 02/02/15
US8829199 333 Aminopyrazole derivative Chugai Seiyaku Kabushiki Kaisha; F. Hoffmann-La Roche AG 02/02/15
US8822505 100 Azetidine derivatives Genentech, Inc. 02/02/15
US8829200 30 Benzimidazole inhibitors of leukotriene production Boehringer Ingelheim International GmbH 02/02/15
US8822460 15 Fused cyclopentyl antagonists of CCR2 Janssen Pharmaceutica NV 02/02/15
US8822494 47 Heteroaromatic compounds and their use as dopamine D1 ligands Pfizer Inc. 02/02/15
US8822447 155 Indazole compounds useful as ketohexokinase inhibitors Janssen Pharmaceutica NV 02/02/15
US8822457 4 Inhibitors of bruton's tyrosine kinase Roche Palo Alto LLC 02/02/15
US8822448 100 Pyrazoloquinoline compound Astellas Pharma Inc. 02/02/15
US8822510 15 Substituted 3-phenyl-1,2,4-Oxadiazole compounds Bristol-Myers Squibb Company 02/02/15
US8822458 61 Substituted oxazolidinones and their use in the field of blood coagulation Bayer Intellectual Property GmbH 02/02/15
US8822500 55 Tyrosine kinase inhibitors Chembridge Corporation 02/02/15
US8815881 20 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds Hoffmann-La Roche Inc.; Siena Biotech S.p.A. 01/26/15
US8815845 10 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties The Regents of the University of Michigan 01/26/15
US8815927 11 Bivalent diazo bicyclic Smac mimetics and the uses thereof The Regents of the University of Michigan 01/26/15
US8815852 34 Carbamoyloxy arylalkan arylpiperazine analgesics SK Biopharmaceuticals Co., Ltd. 01/26/15
US8815840 94 Carbazole and carboline kinase inhibitors Bristol-Myers Squibb Company 01/26/15
US8815918 14 Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives Centro Nacional de Investigaciones Oncologicas (CNIO) 01/26/15
US8815901 52 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors Novartis AG 01/26/15
US8822534 22 Substituted aminopropionic derivatives as neprilysin inhibitors Novartis AG 01/26/15
US8815854 24 Substituted imidazopyridinyl compounds ArQule, Inc. 01/26/15
US8815926 334 Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases Novartis AG 01/26/15
US8815891 114 Tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same Je Il Pharmaceutical Co., Ltd. 01/26/15
US8815934 54 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations Wyeth LLC 01/19/15
US8802674 212 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 01/19/15
US8816088 96 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Theravance Respiratory Company, LLC 01/19/15
US8802679 44 Glycine compound Astellas Pharma Inc. 01/19/15
US8802673 421 Heterocyclic amine derivatives Hoffmann-La Roche Inc 01/19/15
US8815951 300 Inhibitors of epoxide hydrolases for the treatment of inflammation The Regents of the University of California 01/19/15
US8802663 45 Pyrazole oxadiazole derivatives as S1P1 agonists Merck Serono SA 01/19/15
US8802712 80 Pyrazoloquinolines Merck Patent GmbH 01/19/15
US8802672 27 Pyrimidinyl-piperazines useful as D3/D2 receptor ligands Richter Gedeon Nyrt. 01/19/15
US8802665 48 Pyrrolidine derivatives Genentech, Inc. 01/19/15
US8802686 63 Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicine Bayer Intellectual Property GmbH 01/19/15
US8802711 155 TRPV1 antagonists AbbVie Inc. 01/19/15
US8796280 46 2,3-disubstituted pyrazinesulfonamides as CRTH2 inhibitors Merck Serono, S.A. 01/12/15
US8796284 21 4-aminopyrimidine derivatives and their as as adenosine A2a receptor antagonists Palobiofarma, S.L. 01/12/15
US8796296 33 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 01/12/15
US8802695 41 Apoptosis signal-regulating kinase 1 inhibitors Takeda Pharmaceutical Company Limited 01/12/15
US8796244 586 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases Astex Therapeutics Ltd 01/12/15
US8802724 5 Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans Purdue Research Foundation 01/12/15
US8796293 9 Purine and deazapurine derivatives as pharmaceutical compounds Astex Therapeutics Limited; The Institute of Cancer Research: Royal Cancer Hospital; Cancer Research Technology Limited 01/12/15
US8796295 30 Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same Vanderbilt University 01/12/15
US8802861 17 Thiazole derivatives and use thereof Merck Serono SA 01/12/15
US8802721 9 Thiophene compounds for inflammation and immune-related uses Synta Pharmaceuticals Corp. 01/12/15
US8802864 12 Triazolones as fatty acid synthase inhibitors GlaxoSmithKline LLC 01/12/15
US8796297 46 4-substituted-2-amino-pyrimidine derivatives AbbVie Inc. 12/22/14
US8796310 83 Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors Merck Sharp & Dohme Corp. 12/22/14
US8791130 46 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 12/22/14
US8791100 79 Aryl benzylamine compounds Novartis AG 12/22/14
US8796457 1 Compound useful for the treatment of degenerative and inflammatory diseases Galapagos NV 12/22/14
US8796330 80 Inhibitors of histone deacetylase and prodrugs thereof Methylgene Inc. 12/22/14
US8791118 38 Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors Aeterna Zentaris GmbH 12/22/14
US8791123 504 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors Array Biopharma, Inc. 12/22/14
US8796328 44 TRPV1 antagonists TBA 12/22/14
US8796304 19 Tricyclic imidazole compounds as PDE10 inhibitors H. Lundbeck A/S 12/22/14
US8785467 20 Alkoxy pyrimidine PDE10 inhibitors Merck Sharp & Dohme Corp. 12/16/14
US8785489 97 Heteroaryl substituted indole compounds useful as MMP-13 inhibitors Boehringer Ingelheim International GmbH 12/16/14
US8785477 9 Hexahydropyrrolo[3,4-b]pyrrole derivatives, preparation methods and pharmaceutical uses thereof Shanghai Sun-Sail Pharmaceutical Science & Technology Co., Ltd. 12/16/14
US8791131 292 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions Pfizer Inc. 12/16/14
US8791272 215 Pyrazole compounds as CRTH2 antagonists Boehringer Ingelheim International GmbH 12/16/14
US8785464 81 Pyrimidine derivatives that inhibit FAK/PTK2 Boehringer Ingelheim International GmbH 12/16/14
US8785459 386 Quinazoline compounds as kinase inhibitors Development Center for Biotechnology 12/16/14
US8791257 60 Substituted pyrrolotriazines as protein kinase inhibitors Bristol-Myers Squibb Company 12/16/14
US8791268 22 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions Gruenenthal GmbH 12/16/14
US8778932 5 Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing them Les Laboratoires Servier; Egis Gyogyszergyar Nyrt 12/15/14
US8785634 9 Spiropiperidine prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp 12/15/14
US8785499 8 Targeting NAD biosynthesis in bacterial pathogens University of Maryland, Baltimore; The Board of Regents of the University of Texas System; Sanford-Burnham Medical Research Institute 12/15/14
US8779142 157 Azabicyclo compound and salt thereof Taiho Pharmaceutical Co., Ltd. 12/08/14
US8772304 33 Benzimidazole inhibitors of leukotriene production Boehringer Ingelheim International GmbH 12/08/14
US8772285 2 Benzothiazoles having histamine H3 receptor activity High Point Pharmaceuticals, LLC 12/08/14
US8778970 55 Benzyl piperidine compound Dainippon Sumitomo Pharma Co., Ltd 12/08/14
US8778957 21 CGRP receptor antagonists Merck Sharp & Dohme Corp. 12/08/14
US8778951 352 Heteroaryl compounds and their uses Novartis AG 12/08/14
US8772283 128 Imidazo-oxazine compound or salt thereof Taiho Pharmaceutical Co., Ltd. 12/08/14
US8778412 32 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha Aerpio Therapeutics Inc. 12/08/14
US8772288 36 Substituted spiro[cycloalkyl-1,3′-indo]-2′(1′H)-one derivatives and their use as P38 mitogen-activated kinase inhibitors Almirall, S.A. 12/08/14
US8772297 20 TGF-β signal transduction inhibitor Kyoto University 12/08/14
US8772282 6 Tetrahydropyrrolothiazine compounds Eli Lilly and Company 12/08/14
US8785638 71 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors Katholieke Universiteit Leuven 12/08/14
US8772495 1 5-lipoxygenase-activating protein inhibitor Panmira Pharmaceuticals, LLC 11/24/14
US8765733 21 Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands Gruenenthal GmbH 11/24/14
US8772481 21 Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof Amgen Inc. 11/24/14
US8772511 7 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists Bayer Intellectual Property GmbH 11/24/14
US8765744 129 Azaspirohexanones Boehringer Ingelheim International GmbH 11/24/14
US8772478 21 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics Galderma Research & Development 11/24/14
US8772480 690 Inhibitors of PI3 kinase and/or mTOR Amgen Inc. 11/24/14
US8772508 17 Inhibitors of glutaminyl cyclase Probiodrug AG 11/24/14
US8765727 95 Macrocyclic compounds and their use as kinase inhibitors Incyte Corporation 11/24/14
US8772510 65 PDE10 modulators Hoffmann-La Roche Inc. 11/24/14
US8772316 84 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) Allergan, Inc.; Exonhit Therapeutics SA 11/24/14
US8772305 292 Substituted pyridinyl-pyrimidines and their use as medicaments Boehringer Ingelheim International GmbH 11/24/14
US8765972 19 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides with selective PARP-1 inhibition Nerviano Medical Sciences S.r.l. 11/18/14
US8759537 85 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents Boehringer Ingelheim International GmbH 11/18/14
US8759366 48 Aminopyrimidines as SYK inhibitors Merck Sharp & Dohme Corp.; Merck Canada Inc. 11/18/14
US8759341 15 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof Bayer Intellectual Property GmbH 11/18/14
US8765747 21 Fused 2-aminothiazole compounds Dana-Farber Cancer Institute, Inc. 11/18/14
US8765940 162 Heterocyclic compounds and their uses Amgen Inc. 11/18/14
US8759338 57 Heterocyclic kinase inhibitors Novartis AG 11/18/14
US8759365 23 Organic compounds Novartis AG 11/18/14
US8765750 27 Piperazine compound having a PGDS inhibitory effect Taiho Pharmaceutical Co., Ltd. 11/18/14
US8759386 59 Pyrazole compounds as CRTH2 antagonists Boehringer Ingelheim International GmbH 11/18/14
US8759532 266 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors Amgen Inc. 11/18/14
US8765820 21 Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2 Universita Degli Studi di Roma “La Sapienza”; Fondazione IEO; Universita Degli Studi di Pavia; Universita Degli Studi di Milano 11/18/14
US8754075 87 1,3-oxazines as BACE1 and/or BACE2 inhibitors Hoffmann-La Roche Inc. 11/11/14
US8748418 53 1,4-oxazepines as BACE1 and/or BACE2 inhibitors Hoffmann-La Roche Inc. 11/11/14
US8748608 39 4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use The United States of America as Represented by the Secretary of the Department of Health and Human Services; The University of North Texas Health Science Center at Fort Worth 11/11/14
US8748451 35 HDAC inhibitors and therapeutic methods of using same The Board of Trustees of The University of Illinois 11/11/14
US8754089 32 Heterocyclic compounds and their uses Amgen Inc. 11/11/14
US8754106 9 Macrocyclic inhibitors of hepatitis C virus Janssen R&D Ireland; Medivir AB 11/11/14
US8754105 6 Macrocyclic inhibitors of hepatitis C virus Medivir AB; Janssen R&D Ireland 11/11/14
US8754227 15 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 11/11/14
US8754099 5 Oxadiazole beta carboline derivatives as antidiabetic compounds Merck Sharp & Dohme Corp 11/11/14
US8754113 39 Oxadiazole derivative having endothelial lipase inhibitory activity Shionogi & Co., Ltd. 11/11/14
US8754233 151 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents Dermira (Canada), Inc. 11/11/14
US8748458 41 Scriptaid isosteres and their use in therapy Karus Therapeutics Limited 11/11/14
US8741907 16 Alkyl-substituted pyrazolopyrimidines Boehringer Ingelheim International GmbH 11/05/14
US8741944 37 Anti-infective agents against intracellular pathogens The Ohio State University Research Foundation 11/05/14
US8741915 24 Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors N30 Pharmaceuticals, Inc. 11/05/14
US8742106 172 Disubstituted heteroaryl-fused pyridines Novartis AG 11/05/14
US8748618 36 Inhibitors of inv(16) leukemia University of Virginia Patent Foundation 11/05/14
US8741926 10 Macrocyclic inhibitors of hepatitis C virus Janssen R&D Ireland; Medivir AB 11/05/14
US8741923 19 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis Merck Serono SA 11/05/14
US8748626 8 Oxazole and thiazole compounds as KSP inhibitors Novartis AG 11/05/14
US8748624 138 Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists Janssen Pharmaceutica NV 11/05/14
US8748435 37 Pyrazolo pyrimidine derivatives Novartis AG 11/05/14
US8742113 21 Furanone derivative SBI Biotech Co., Ltd.; Carna Biosciences, Inc. 11/04/14
US8742110 170 Spiroxazolidinone compounds Merck Sharp & Dohme Corp. 11/04/14
US8729113 97 4,5-dihydro-oxazol-2yl derivatives Hoffmann-La Roche Inc. 10/28/14
US8742134 8 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof Theron Pharmaceuticals, Inc. 10/28/14
US8735386 429 Aminopyrazoloquinazolines Boehringer Ingelheim International GmbH 10/28/14
US8735593 10 Aminopyridines useful as inhibitors of protein kinases Vertex Pharmaceuticals Incorporated 10/28/14
US8742115 35 Co-crystals and salts of CCR3-inhibitors Boehringer Ingelheim International GmbH 10/28/14
US8722692 731 Compounds and compositions as Syk kinase inhibitors TBA 10/28/14
US8742138 35 Compounds as hypoxia mimetics, and compositions and uses thereof Betta Pharmaceuticals Co., Ltd. 10/28/14
US8729074 47 Inhibitors of PI3 kinase Amgen Inc. 10/28/14
US8729078 50 Inhibitors of bruton's tyrosine kinase Hoffmann-La Roche Inc. 10/28/14
US8735395 13 Protease inhibitors Medivir AB 10/28/14
US8742158 44 Protease inhibitors TaiMed Biologies, Inc. 10/28/14
US8729061 248 Pyrrolidine derivatives Hoffmann-La Roche Inc. 10/28/14
US8722877 5 7-deazapurine modulators of histone methyltransferase, and methods of use thereof Epizyme, Inc. 10/20/14
US8722683 231 Benzodioxole piperazine compounds Hoffmann LA-Roche Inc. 10/20/14
US8716478 12 Boron-containing small molecules Anacor Pharmaceuticals, Inc. 10/20/14
US8729273 31 Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same LG Life Sciences Ltd. 10/20/14
US8722718 2 Inhibitors of C-FMS kinase Janssen Pharmaceutica NV 10/20/14
US8716296 11 Inhibitors of protein kinases Ingenium Pharmaceuticals GmbH 10/20/14
US8722709 57 Mineralocorticoid receptor antagonists Boehringer Ingelheim International GmbH 10/20/14
US8716285 65 N-hydroxy-benzamids for the treatment of cancer Hoffmann-La Roche Inc. 10/20/14
US8716287 65 Pharmaceutical compounds Sentinel Oncology Limited 10/20/14
US8722896 588 Prokineticin receptor antagonists and uses thereof The Regents of the University of California 10/20/14
US8722895 34 Prolyl hydroxylase inhibitors and method of use Akebia Therapeutics, Inc. 10/20/14
US8722721 18 SEC-hydroxycyclohexyl derivatives Hoffmann-La Roche Inc. 10/20/14
US8722890 54 Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profile AbbVie Inc. 10/20/14
US8710076 8 2,5-disubstituted piperidine orexin receptor antagonists Merck Sharp & Dohme Corp. 10/14/14
US8703785 9 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity Shionogi & Co., Ltd. 10/14/14
US8703807 12 Azaspirodecanone compounds Hoffmann-La Roche Inc. 10/14/14
US8703947 11 Compounds for treatment of Alzheimer's disease Purdue Research Foundation 10/14/14
US8703720 17 Galactoside inhibitors of galectins Galecto Biotech AB 10/14/14
US8710232 17 Imidazole derivatives used as TAFIa inhibitors Sanofi-Aventis Deutschland GmbH 10/14/14
US8703768 340 Nitrogen containing heteroaryl compounds Hoffmann-La Roche Inc. 10/14/14
US8703761 15 Organic compounds Novartis AG 10/14/14
US8703771 45 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor Harbin Gloria Pharmaceuticals Co., Ltd. 10/14/14
US8703770 2 Pyridazine carboxamide orexin receptor antagonists Merck Sharp & Dohme Corp. 10/14/14
US8703811 138 Small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase Genzyme Corporation; Massachusetts Institute of Technology; President and Fellows of Harvard College 10/14/14
US8703767 18 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors University of Utah Research Foundation 10/14/14
US8716482 17 Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp. 10/14/14
US8697869 57 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators Actelion Pharmaceuticals Ltd. 10/06/14
US8697868 10 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions Boehringer Ingelheim International GmbH 10/06/14
US8697708 16 Azabenzothiazole compounds, compositions and methods of use F. Hoffmann-La Roche AG 10/06/14
US8697716 17 Method of inhibiting C-KIT kinase Janssen Pharmaceutica NV 10/06/14
US8691753 866 Pseudodipeptides as MMP inhibitors Commissariat A l'Energie Atomique et Aux Energies Alternatives 10/06/14
US8697911 172 Rho kinase inhibitors Boehringer Ingelheim International GmbH 10/06/14
US8697715 42 Serine/threonine kinase inhibitors Array BioPharma, Inc.; Genentech, Inc. 10/06/14
US8697696 11 Triazole compounds II Roche Palo Alto LLC 10/06/14
US8691852 26 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors Amirall, S.A. 09/30/14
US8691827 9 Amino tetrahydro-pyridopyrimidine PDE10 inhibitors Merck Sharp & Dohme Corp. 09/30/14
US8691986 34 Azetidine and piperidine compounds useful as PDE10 inhibitors Amgen Inc. 09/30/14
US8691856 2 Glucagon receptor antagonists, preparation and therapeutic uses Eli Lilly and Company 09/30/14
US8691840 5 N-biarylamides Bayer Intellectual Property GmbH 09/30/14
US8691993 13 Piperidinyl naphthylacetic acids Hoffmann-La Roche Inc. 09/30/14
US8685958 20 Therapeutic agents AstraZeneca AB 09/30/14
US8691829 4 Treatment of liver disorders with PI3K inhibitors Gilead Calistoga LLC 09/30/14
US8691832 20 Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 09/30/14
US8680119 4 Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Arena Pharmaceuticals, Inc. 09/16/14
US8680275 351 Fused heterocyclic compounds as orexin receptor modulators Janssen Pharmaceutica NV 09/16/14
US8686042 2 GSK-3 inhibitors Neuropharma, S.A. 09/16/14
US8685992 120 Histone deacetylase inhibitors based simultaneously on trisubstituted 1H-pyrroles and aromatic and heteroaromatic spacers Universidad del País Vasco; Ikerschem, S.L. 09/16/14
US8680120 31 Indole derivative or pharmaceutically acceptable salt thereof Kissei Pharmaceutical Co., Ltd. 09/16/14
US8685986 12 Medical composition for treatment or prophylaxis of glaucoma Ube Industries, Ltd. 09/16/14
US8686018 9 Pharmaceutical composition Eisai R&D Management Co., Ltd. 09/16/14
US8680116 9 Quinolinone PDE2 inhibitors Merck Sharp & Dohme Corp. 09/16/14
US8680132 72 Spiro-oxindole MDM2 antagonists The Regents of the University of Michigan; Ascenta Licensing Corporation; Sanofi 09/16/14
US8673938 23 Chemical compounds AstraZeneca AB 09/08/14
US8673906 102 Chromenone derivatives AstraZeneca AB 09/08/14
US8673950 149 Dihydrooxazol-2-amine derivatives Hoffmann-LaRoche Inc. 09/08/14
US8669380 8 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives Pfizer Inc. 09/08/14
US8673905 42 Imidazo pyrazines Hoffmann-La Roche Inc. 09/08/14
US8669252 14 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp. 09/08/14
US8669361 86 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use F. Hoffmann-La Roche AG 09/08/14
US8669266 17 Quinoline-carboxamide derivatives as P2Y12 antagonists Sanofi 09/08/14
US8673966 123 ALDH-2 inhibitors in the treatment of addiction Gilead Sciences, Inc. 09/03/14
US8674113 185 Compounds Boehringer Ingelheim International GmbH 09/03/14
US8653125 23 Cyclohexane derivative having NPY Y5 receptor antagonism Shionogi Co., Ltd. 09/03/14
US8653263 733 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Janssen Pharmaceutica 09/03/14
US8674100 93 Inhibitors of C-FMS kinase Janssen Pharmaceutica, N.V. 09/03/14
US8653111 20 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Bayer Intellectual Property GmbH 09/03/14
US8653092 188 Tetrahydro-pyrido-pyrimidine derivatives Novartis AG 09/03/14
US8664236 35 1H-pyrrolo[2,3 b]-pyridine derivatives Merck Patent GmbH 08/26/14
US8664219 26 Aminopyrimidines useful as inhibitors of protein kinases Vertex Pharmaceuticals Incorporated 08/26/14
US8648092 144 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications MEI Pharma 08/26/14
US8664258 5 Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Arena Pharmaceuticals, Inc. 08/26/14
US8653091 46 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof Evotec AG 08/26/14
US8653087 741 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors Boehringer Ingelheim International GmbH 08/26/14
US8664230 18 Pyridopyrimidine derivatives and use thereof The Asan Foundation 08/26/14
US8637558 130 Thiazolidinedione derivative and use thereof Industry-Academic Cooperation Foundation, Chosun University 08/26/14
US8637502 75 2,3,4,5-tetrahydro-benzo{B}{1,4}diazepine-comprising compounds of formula(III) for treating pain Purde Pharma L.P.; Shionogi & Co., Ltd. 08/22/14
US8633183 1192 5-alkynyl-pyrimidines Boehringer Ingelheim International GmbH 08/22/14
US8637532 1511 Amino azaheterocyclic carboxamides Merck Patent GmbH 08/22/14
US8637500 360 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors Amgen Inc. 08/22/14
US8637508 90 Heterocyclic derivatives and their use in the treatment of neurological disorders Novartis AG 08/22/14
US8637526 40 Pyrazolopyrimidine JAK inhibitor compounds and methods Genentech, Inc. 08/22/14
US8637504 37 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity Shionogi & Co., Ltd. 08/22/14
US8637528 8 Use of PDE7 inhibitors for the treatment of movement disorders Omeros Corporation 08/22/14
US8633204 174 4-methylpyridopyrimidinone compounds Pfizer Inc. 08/06/14
US8633208 48 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands Rottapharm S.p.A 08/06/14
US8633188 60 Aminodihydrothiazine derivatives Shionogi & Co., Ltd. 08/06/14
US8637501 113 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 08/06/14
US8633196 19 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics Galderma Research & Development 08/06/14
US8637507 15 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase Merck Sharp & Dohme Corp. 08/06/14
US8633212 166 Inhibitors of beta-secretase Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 08/06/14
US8633226 5 Piperidinyl derivative as a modulator of chemokine receptor activity Bristol-Myers Squibb Company 08/06/14
US8633206 417 Pyrrolo[2,3-D]pyrimidine compounds Pfizer Inc. 08/06/14
US8633231 20 Substituted imidazolones, compositions containing such compounds and methods of use Merck Sharp & Dohme Corp. 08/05/14
US8629158 46 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 07/28/14
US8623860 151 Azetidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 07/28/14
US8623863 24 Disubstituted azepan orexin receptor antagonists Merck Sharp & Dohme Corp. 07/28/14
US8629282 13 Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases Bristol-Myers Squibb Company 07/28/14
US8629135 14 Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer Queen's University at Kingston 07/28/14
US8629167 93 Selective androgen receptor modulators Radius Health, Inc. 07/28/14
US8628961 13 Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof Tufts University; Council of Scientific and Industrial Research 07/28/14
US8629141 39 Spiro-oxindole MDM2 antagonists The Regents of the University of Michigan; Sanofi 07/28/14
US8629154 10 Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof TBA 07/28/14
US8623883 20 4-phenylamino-quinazolin-6-yl-amides Warner-Lambert Company LLC 07/22/14
US8623865 3 Acylpiperazinones and their use as pharmaceuticals Fab Pharma S.A.S. 07/22/14
US8623901 43 Compounds for the treatment of CNS disorders Boehringer Ingelheim International GmbH 07/22/14
US8623885 48 Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 Amgen Inc. 07/22/14
US8618103 236 Inhibitors of JAK Hoffmann-La Roche Inc. 07/22/14
US8623892 13 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 07/22/14
US8618107 64 Pyridone and aza-pyridone compounds and methods of use Gilead Connecticut, Inc.; Genentech, Inc. 07/22/14
US8623889 490 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof Genentech, Inc. 07/22/14
US8623906 70 Carboxy isatin hydrazones and their esters as Shp2 inhibitors H. Lee Moffitt Cancer Center and Research Institute, Inc. 07/21/14
US8618114 79 Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof TBA 07/09/14
US8618111 284 5-alkynyl-pyrimidines Boehringer Ingelheim International GmbH 07/08/14
US8618286 87 Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity NeurAxon, Inc. 07/08/14
US8618075 9 Certain compounds, compositions and methods Eisai Inc. 07/08/14
US8623903 17 Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity Shionogi & Co., Ltd. 07/08/14
US8618098 4 Inhibitors of bruton's tyrosine kinase Roche Palo Alto LLC 07/08/14
US8618147 16 Modified macrophage migration inhibitory factor inhibitors The Feinstein Institute for Medical Research 07/08/14
US8624022 14 Substituted aniline derivatives UCB Pharma, S.A. 07/08/14
US8618158 80 Therapeutic agents Cancer Research Technology Limited 07/08/14
US8614253 302 IRE-1α inhibitors MannKind Corporation 06/25/14
US8614234 165 Compounds as tyrosine kinase modulators Allergan, Inc. 06/24/14
US8618290 17 HSP90 inhibitors Takeda Pharmaceutical Company Limited 06/24/14
US8613914 197 Peptidomimetic sulfamide compounds and antiviral uses thereof Novartis AG 06/24/14
US8614206 289 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use F. Hoffmann-La Roche AG 06/24/14
US8614215 103 Quinoxaline inhibitors of phosphoinositide-3-kinases (PI3Ks) Merck Serono SA 06/24/14
US8618299 55 Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 06/16/14
US8609647 91 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof Japan Tobacco Inc. 06/16/14
US8618303 36 Pyrrolidine derivatives Hoffmann-La Roche Inc. 06/16/14
US8609678 365 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof Acetylon Pharmaceuticals 06/16/14
US8609681 72 Spirocyclic nitriles as protease inhibitors Sanofi 06/16/14
US8609708 141 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer Human BioMolecular Research Institute 06/16/14
US8604061 221 2-aminooxazolines as TAAR1 ligands Hoffmann-La Roche Inc. 06/04/14
US8609666 67 2-morpholino-pyrido[3,2-D]pyrimidines Merck Serono SA 06/04/14
US8609622 20 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof Shanghai Hengrui Pharmaceutical Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd. 06/04/14
US8609710 29 Cycloalkyl-substituted imidazole derivative Daiichi Sankyo Company, Limited 06/04/14
US8609715 258 Heteroarylcarboxylic acid ester derivative Ajinomoto Co., Inc. 06/04/14
US8609698 8 Substituted dipyridyl-dihydropyrazolones and use thereof Bayer Intellectual Property GmbH 06/04/14
US8604028 6 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof Bayer Intellectual Property GmbH 05/13/14
US8609852 103 Thiazolyl mGluR5 antagonists and methods for their use Merck Sharp & Dohme Corp. 05/13/14
US8604206 18 Compositions for preventing and/or treating degenerative disorders of the central nervous system Amicus Therapeutics, Inc. 05/12/14
US8604016 694 Heterocyclic inhibitors of glutaminase Calithera Biosciences Inc. 05/12/14
US8609688 36 Substituted imidazopyridinyl-aminopyridine compounds ArQule, Inc. 05/12/14
US8604217 78 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent Selvita S.A. 05/05/14
US8609892 2 Glucagon receptor antagonists, preparation and therapeutic uses Eli Lilly and Company 05/05/14
US8598119 47 Methods and compositions for sleep disorders and other disorders Intra-Cellular Therapies, Inc. 05/05/14
US8609833 18 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof Inotek Pharmaceuticals Corporation 05/05/14
US8604046 69 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof Sanofi 05/05/14
US8598157 90 5-alkynyl-pyridines Boehringer Ingelheim International GmbH 04/28/14
US8598163 45 Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 04/28/14
US8598184 5 Protein kinase inhibitors Tiger Pharmatech 04/28/14
US8598172 6 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.r.l. 04/28/14
US8598206 241 Trypsin-like serine protease inhibitors, and their preparation and use The Medicines Company (Leipzig) GmbH 04/28/14
US8604218 166 Cytoskeletal active rho kinase inhibitor compounds, composition and use Inspire Pharmaceuticals, Inc. 04/18/14
US8598155 86 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders Pfizer Inc. 04/18/14
US8598217 20 Imidazole derivatives and their use as modulators of cyclin dependent kinases Astex Therapeutics Ltd.; Novartis AG 04/18/14
US8598200 29 KAT II inhibitors Pfizer Inc. 04/18/14
US8598210 55 Prolyl hydroxylase inhibitors and methods of use Akebia Therapeutics, Inc. 04/18/14
US8592371 8 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Merck Sharpe & Dohme Corp. 04/14/14
US8592426 124 Aryl-benzocycloalkyl amide derivatives Hoffmann—La Roche Inc. 04/14/14
US8598357 237 Benzodioxole piperidine compounds Hoffmann-La Roche Inc. 04/14/14
US8592432 61 Compounds and compositions as protein kinase inhibitors TBA 04/14/14
US8592410 135 Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1 Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 04/14/14
US8575157 341 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International, GmbH 04/14/14
US8592431 151 Fused ring compound and use thereof Takeda Pharmaceutical Company Limited 04/14/14
US8592425 5 Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors Merck Sharp & Dohme Corp. 04/14/14
US8592423 3 Inhibitors of PDE10 Bristol-Myers Squibb Company 04/14/14
US8592379 11 Metastin derivative and use thereof Kyoto University; Takeda Pharmaceutical Company Limited 04/14/14
US8592415 144 Selective kinase inhibitors Reaction Biology Corp.; Synerga Limited 04/14/14
US8598345 91 Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same Vanderbilt University 04/14/14
US8592468 14 Bacterial thioredoxin reductase inhibitors and methods for use thereof Thioredoxin Systems AB 03/17/14
US8592457 5 Isonicotinamide orexin receptor antagonists Merck Sharp & Dohme Corp. 03/17/14
US8592455 417 Kinase inhibitors and methods of their use Novartis AG 03/17/14
US8592454 32 Nitrogen-containing heterocyclic compound and use of same Takeda Pharmaceutical Company Limited 03/17/14
US8592579 45 Pyrrolotriazine kinase inhibitors Bristol-Myers Squibb Company 03/17/14
US8592581 36 Trisubstituted purine derivatives Cyclacel Limited; Cancer Research Technology Limited 03/17/14
US8586580 8 2,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitors Korea Institute of Science and Technology 03/12/14
US8586617 104 Aminomethyl-4-imidazoles Hoffmann-La Roche Inc. 03/12/14
US8586579 423 Anellated pyridine compounds Hoffmann-La Roche Inc. 03/12/14
US8586571 15 Heterocyclic compound Takeda Pharmaceutical Company Limited 03/12/14
US8586600 34 Heterocyclic compounds and uses thereof Celgene Avilomics Research, Inc. 03/12/14
US8586620 134 Substituted indole compounds having NOS inhibitory activity NeurAxon, Inc. 03/12/14
US8580800 9 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use Bayer Intellectual Property GmbH 03/06/14
US8586597 5 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta ICOS Corporation 03/06/14
US8575203 258 Chemical compounds Boehringer Ingelheim International GmbH 03/06/14
US8580788 21 Opioid antagonists Adolor Corporation 03/06/14
US8575197 752 Pyrolinone derivative and pharmaceutical composition comprising the same Shionogi & Co., Ltd. 03/06/14
US8580778 9 Substituted dihydropyrazolones and their use Bayer Intellectual Property GmbH 03/06/14
US8580782 16 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors Merck Sharp & Dohme Corp. 03/06/14
US8575391 31 5-substituted-2-phenylamino benzamides as MEK inhibitors Chugai Seiyaku Kabushiki Kaisha 02/24/14
US8575375 5 Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties Research Triangle Institute; The United States of America, as represented by the Secretary, Department of Health and Human Services 02/24/14
US8569291 11 Bicyclic dihydroimidazolone CGRP receptor antagonists Merck Sharp & Dohme Corp. 02/24/14
US8569281 119 Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK Medical Research Council Technology; Genentech, Inc. 02/24/14
US8580815 16 Derivatives of azaindoles as inhibitors of protein kinases ABL and SRC Oribase Pharma 02/24/14
US8575186 219 Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof Albany Molecular Research, Inc. 02/24/14
US8569306 18 JNK modulators Hoffmann-La Roche, Inc. 02/24/14
US8569313 47 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors The Medicines Company (Leipzig) GmbH 02/24/14
US8575364 66 Modulators of serotonin receptor Janssen Pharmaceutica NV 02/24/14
US8575201 175 Oxadiazole inhibitors of leukotriene production Boehringer Ingelheim International GmbH 02/24/14
US8569299 10 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp 02/24/14
US8569311 48 Pyridyl piperidine orexin receptor antagonists Merch Sharp & Dohme Corp. 02/24/14
US8569316 64 Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases Boehringer Ingelheim International GmbH 02/24/14
USRE44599 5 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta ICOS Corporation 02/24/14
US8575114 43 SGLT-2 inhibitors, methods of making them, and uses thereof Albany Molecular Research, Inc. 02/24/14
US8569308 118 Substituted heteroarylamine carboxamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same Vanderbilt University 02/24/14
US8569314 10 Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD Bayer Intellectual Property GmbH 02/24/14
US8575145 329 Triazolopyridine compounds as PIM kinase inhibitors Array BioPharma Inc. 02/24/14
US8569521 10 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors Merck Sharp & Dohme Corp. 01/21/14
US8569318 7 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof TBA 01/21/14
US8569338 3 Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds Proximagen Ltd. 01/20/14
US8563583 6 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists Bristol-Myers Squibb Company 01/20/14
US8569511 40 Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase University of Utah Research Foundation 01/20/14
US8562945 22 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof Molecular Insight Pharmaceuticals, Inc. 01/20/14
US8551988 144 Benzimidazole derivatives: preparation and pharmaceutical applications Mei Pharma, Inc. 01/14/14
US8563545 42 Compound useful for the treatment of degenerative and inflammatory diseases Galapagos NV 01/14/14
US8563553 103 Compounds and compositions as protein kinase inhibitors Novartis AG; IRM LLC 01/14/14
US8551978 95 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Theravance, Inc. 01/14/14
US8551963 10 Imidazolothiazole compounds and methods of use thereof Ambit Biosciences Corporation 01/14/14
US8563594 17 S1P3 receptor inhibitors for treating pain Allergan, Inc. 01/14/14
US8552005 16 (EN) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof Avincuro Pharmaceuticals, Inc. 01/03/14
US8552017 4 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof TBA 01/03/14
US8552004 30 Chemical compounds AstraZeneca AB 01/03/14
US8546370 24 Compounds and compositions as kinase inhibitors IRM LLC 01/03/14
US8552023 5 Non-amidic linkers with branched termini as CGRP receptor antagonists Merck Sharp & Dohme Corp. 01/03/14
US8551989 12 Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof Bayer Intellectual Property GmbH 01/03/14
US8546380 61 Aminodihydrothiazine derivatives Shionogi & Co., Ltd. 12/22/13
US8552202 105 Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors Amura Therapeutics Limited 12/22/13
US8552033 2 Inhibitors of CXCR2 SANOFI 12/22/13
US8552057 12 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases University of Southern California 12/22/13
US8552037 42 Tricyclic compound and pharmaceutical use thereof Takeda Pharmaceutical Company Limited 12/22/13
US8546392 59 17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases Universitaet des Saarlandes 12/09/13
US8546404 17 Compounds that are ERK inhibitors Merck Sharp & Dohme 12/09/13
US8552199 24 Substituted indanes, method for the production thereof, and use thereof as drugs Sanofi 12/09/13
US8546434 14 Triazole compounds as KSP inhibitors Novartis AG 12/09/13
US8546389 76 Viral polymerase inhibitors Biota Scientific Management Pty Ltd. 12/09/13
US8541380 97 C-aryl glucoside SGLT2 inhibitors and pharmaceutical compositions comprising same Green Cross Corporation 12/03/13
US8546451 20 Estrogen receptor ligands and methods of use thereof GTx, Inc. 12/03/13
US8541363 4 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use St George's Hosptial Medical School; The University of Manchester 12/03/13
US8541407 230 Substituted benzo-pyrido-triazolo-diazepine compounds ArQule, Inc. 12/03/13
US8546435 9 Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors AEterna Zentaris GmbH; Centre National de la Recherche Scientifique; University of Montpellier I; University of Montpellier II 12/03/13
US8541447 6 3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof Targacept, Inc. 11/26/13
US8541408 48 Aminodihydrothiazine derivatives substituted with a cyclic group Shionogi & Co., Ltd. 11/26/13
US8541572 292 Compounds for the treatment of inflammatory disorders Merck Sharp & Dohme Corp. 11/26/13
US8541596 10 Inhibitors Probiodrug AG 11/26/13
US8541427 45 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use Merck, Sharp & Dohme, Corp. 11/26/13
US8536165 55 Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors Almirall, S.A. 11/18/13
US8536158 8 Compounds having CRTH2 antagonist activity Atopix Therapeutics Limited 11/18/13
US8536166 4 Inhibitors of Burton's tyrosine kinase Roche Palo Alto LLC 11/18/13
US8536172 106 Inhibitors of JNK Roche Palo Alto LLC 11/18/13
US8536175 50 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors Novartis AG 11/18/13
US8536173 10 Tetrahydroquinoxaline urea derivatives as modulators of 11-B-hydroxysteroid dehydrogenase type I SANOFI 11/18/13
US8536192 53 6,7-unsaturated-7-carbamoyl substituted morphinan derivative Shionogi & Co. Ltd. 11/11/13
US8536210 19 Compounds for inhibiting semicarbazide-sensitive amine oxidase (SSAO)/vascular adhesion protein-1 (VAP-1) and uses thereof for treatment and prevention of diseases Semmelweis Egyetem 11/11/13
US8536193 14 Inhibitors of AKT activity Merck Sharp & Dohme Corp.; MSD K.K. 11/11/13
US8536198 23 Piperidine derivatives as modulators of chemokine receptor activity Bristol-Myers Squibb Company 11/11/13
US8536181 32 Prolyl hydroxylase inhibitors Aerpio Therapeutics Inc. 11/11/13
US8530460 200 Azetidine derivatives Boehringer Ingelheim International GmbH 11/04/13
US8530648 404 Diaza-spiro[5.5]undecanes Novartis AG 11/04/13
US8536227 10 Modulators of protein kinase signaling Novotyr Therapeutics Ltd. 11/04/13
US8530504 83 Pyrazolothiazole compound Eisai R&D Management Co., Ltd. 11/04/13
US8530490 143 Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity Taiho Pharmaceutical Co., Ltd. 11/04/13
US8530494 94 Buprenophine analogs Purdue Pharma LP 10/25/13
US8530670 5 Inhibitors Probiodrug AG 10/25/13
US8524716 27 Macrocyclic indoles as hepatitis C virus inhibitors Janssen R&D Ireland 10/25/13
US8524710 86 Pyrrolidine derivatives Hoffmann-La Roche Inc. 10/25/13
US8530652 86 Pyrrolopyrazoles, potent kinase inhibitors Agouron Pharmaceuticals, Inc.; Pfizer Inc. 10/25/13
US8524699 11 Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors Bayer Intellectual Property GmbH 10/25/13
US8507477 10 3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists Merck, Sharp & Dohme, Corp. 10/18/13
US8524917 157 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity Allergan, Inc. 10/18/13
US8507479 48 Aminodihydrothiazine derivatives substituted with a cyclic group Shionogi & Co., Ltd. 10/18/13
US8524717 175 Oxidase inhibitors and their use Oryzon Genomics, S.A. 10/18/13
US8524722 21 Substituted tricyclic compounds and methods of use thereof Bayer Intellectual Property GmbH 10/18/13
US8507510 190 Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents Bayer Intellectual Property GmbH 10/18/13
US8524909 65 Tetrahydro-pyran derivatives Hoffmann-La Roche Inc. 10/18/13
US8507714 18 7-membered ring compound and method of production and pharmaceutical application thereof Daiichi Sankyo Company, Limited 10/07/13
US8501732 211 Aminomethyl quinolone compounds Hoffmann-La Roche Inc. 10/07/13
US8507683 7 Compounds for the treatment of hepatitis C Bristol-Myers Squibb Company 10/07/13
US8507533 84 Glucagon receptor modulators Pfizer Inc. 10/07/13
US8507676 92 Heterocyclic oxime compounds Novartis AG 10/07/13
US8507535 25 Methyl-pyrrolidine ether derivatives Hoffmann-La Roche Inc. 10/07/13
US8501749 31 Azaquinazolinediones chymase inhibitors Boehringer Ingelheim International GmbH 09/30/13
US8501981 6 CXCR2 inhibitors SANOFI 09/30/13
US8501783 79 Conformationally restricted urea inhibitors of soluble epoxide hydrolase The Regents of the University of California 09/30/13
US8501944 20 Inhibitors of protein kinases Portola Pharmaceuticals, Inc. 09/30/13
US8501744 22 Piperazine compounds Amura Therapeutics, Limited 09/30/13
US8501729 34 5-HT3 receptor modulators, methods of making, and use thereof Albany Molecular Research, Inc. 09/16/13
US8501961 20 HIV protease inhibitors and methods for using Purdue Research Foundation 09/16/13
US8501750 52 Heterocyclic compound and use thereof Takeda Pharmaceutical Company Limited 09/16/13
US8501767 18 Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors CSIR 09/16/13
US8501991 6 P53 activating compounds University Court of the University of Dundee; University Court of the University of St. Andrews 09/16/13
US8501936 1030 Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives Cephalon, Inc. 09/16/13
US8497281 179 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 09/10/13
US8497274 6 Heterocyclic compound and use thereof Takeda Pharmaceutical Company Limited 09/10/13
US8497368 79 Heterocyclic hydrazone compounds Novartis AG 09/10/13
US8501768 36 Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds Hoffmann-La Roche Inc. 09/10/13
US8501708 57 Adenosine compounds and their use thereof Inotek Pharmaceuticals Corporation 09/09/13
US8497265 327 Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors Amgen Inc. 09/09/13
US8497385 6 Bryostatin analogues, synthetic methods and uses The Board of Trustees of the Leland Stanford Junior University 09/03/13
US8497288 40 Hexahydropyrroloimidazolone compounds Hoffmann-La Roche Inc. 09/03/13
US8497277 12 Inhibitors of Bruton's tyrosine kinase Pharmacyclics, Inc. 09/03/13
US8497376 27 Inhibitors of c-fms kinase Janssen Pharmaceutica N.V. 09/03/13
US8497270 8 Macrocyclic integrase inhibitors Elanco Animal Health Ireland Limited 09/03/13
US8497286 18 Organic compounds Novartis AG 09/03/13
US8487093 224 -lactamase inhibitors Merck Sharp & Dohme Corp. 09/03/13
US8470847 15 Derivatives of 7-alkynyl-1,8-Naphthyridones, Preparation Method Therefore and Use of Same in Therapeutics Sanofi 08/29/13
US8476306 120 Urokinase inhibitors, production and use thereof The Medicines Company 08/29/13
US8492394 16 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl-thiomorpholin-4-yl) derivatives of 6,7-dialkoxy-quinazoline, 6,7-dialkoxyphtalazine and 6,7-dialkoxyisoquinoline as PDE10A enzyme inhibitors H. Lundbeck A/S 08/28/13
US8492387 9 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease Merck, Sharp & Dohme, Corp. 08/28/13
US8492392 17 Alkoxy tetrahydro-pyridopyrimidine PDE10 inhibitors Merck Sharp & Dohme Corp. 08/28/13
US8492408 4 Benzimidazole derivatives and their use for modulating the GABAA receptor complex Aniona APS 08/28/13
US8492568 1 Chromane derivatives as TRPV3 modulators Glenmark Pharamceuticals S.A. 08/28/13
US8492564 11 Salvinorin derivatives and uses thereof The McLean Hospital Corporation; Temple University School of Medicine 08/28/13
US8486940 185 Inhibitors Probiodrug AG 08/19/13
US8486989 1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease Vertex Pharmaceuticals Incorporated 08/19/13
US8481733 348 Substituted imidazopyr- and imidazotri-azines OSI Pharmaceuticals, LLC 08/19/13
US8487111 8 Substituted oxazolidinones and their use Bayer Intellectual Property GmbH 08/19/13
US8492379 10 Translocator protein ligands The University of Sydney 08/19/13
US8486966 24 9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer Astrazeneca AB 08/12/13
US8481536 323 Benzotriazine inhibitors of kinases TargeGen, Inc. 08/12/13
US8487096 5 Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors Incyte Corporation 08/12/13
US8481743 8 Phenylpropionamide compounds and the use thereof Purdue Pharma L.P. 08/12/13
US8481586 11 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors Centre National de la Recherche Scientifique; Universite Blaise Pascal-Clermont-Ferrand II 08/12/13
US8486953 20 Thienopyrimidines for pharmaceutical compositions Boehringer Ingelheim International GmbH 08/12/13
US8476225 66 Antiviral compounds Gilead Sciences, Inc. 08/05/13
US8486964 9 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors Merck Patent GmbH 08/05/13
US8476267 8 Imidazo-, pyrazolopyrazines and imidazotriazines and their use Bayer Intellectual Property GmbH 08/05/13
US8481564 14 Inhibitors of c-fms kinase Janssen Pharmaceutica, N.V. 08/05/13
US8476271 28 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators Purdue Pharma, L.P.; Shionogi & Co., Ltd. 08/05/13
US8476295 12 Bridged bicyclic RHO kinase inhibitor compounds, composition and use Inspire 07/29/13
US8476255 38 Histone deacetylase inhibitors Orchid Chemicals & Pharmaceuticals Limited 07/29/13
US8476284 14 Inhibitors of Bruton's tyrosine kinase Pharmacyclics, Inc. 07/29/13
US8470843 15 Azacyclic compounds Hoffmann-La Roche Inc. 07/24/13
US8470888 8 Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer The United States of America, as represented by the Secretary, Department of Health and Human Services 07/24/13
US8470836 40 Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent LG Life Sciences, Ltd. 07/24/13
US8470841 39 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof Sanofi 07/24/13
US8470837 44 MAPK/ERK kinase inhibitors Takeda Pharmaceutical Company Limted 07/24/13
US8470835 3 Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase Glaxo Group Limited 07/24/13
US8470825 17 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP Eisai Inc. 07/08/13
US8470800 10 Method of reducing intraocular pressure in humans Inotek Pharmaceuticals Corporation 07/08/13
US8470820 64 Nitrogen-containing heteroaryl derivatives Hoffman-La Roche Inc. 07/08/13
US8470816 43 Nitrogen-containing heterocyclic compound and use thereof Takeda Pharmaceutical Company Limited 07/08/13
US20130102619 122 2-pyridyloxy-4-nitrile orexin receptor antagonists TBA 06/25/13
US20130089624 1 Compounds useful as inhibitors of atr kinase Vertex Pharmaceuticals 06/24/13